UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2017

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________to_________

 

Commission File Number

000-23115

CTI INDUSTRIES CORPORATION

(Exact name of Registrant as specified in its charter)

 

Illinois   36-2848943
(State or other jurisdiction of   (I.R.S. Employer Identification Number)
incorporation or organization)    
     
22160 N. Pepper Road    
Lake Barrington, Illinois   60010
(Address of principal executive offices)   (Zip Code)

 

(847) 382-1000
(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  þ      No  ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  þ      No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ¨   Accelerated filer  ¨   Non-accelerated filer  ¨   Smaller Reporting Company  þ
            Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨      No  þ

 

The number of shares outstanding of the Registrant’s common stock as of November 1, 2017 was 3,525,227.

 

 

 

 

 

 

INDEX

  

Part I – Financial Information  
     
Item No. 1. Financial Statements  
  Condensed Consolidated Balance Sheets at September 30, 2017 (unaudited) and December 31, 2016 1
  Condensed Consolidated Statements of Comprehensive Income  (unaudited) for the three and nine months ended September 30, 2017 and  September 30, 2016 2
  Condensed Consolidated Statements of Cash Flows (unaudited) for the three months ended September 30, 2017 and September 30, 2016 3
  Condensed Consolidated Earnings per Share (unaudited) for the nine months ended September 30, 2017 and September 30, 2016 4
  Notes to Condensed Consolidated Financial Statements (unaudited) 5
Item No. 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item No. 3 Quantitative and Qualitative Disclosures Regarding Market Risk 24
Item No. 4 Controls and Procedures 24
     
Part II – Other Information  
     
Item No. 1 Legal Proceedings 24
Item No. 1A Risk Factors 24
Item No. 2 Unregistered Sales of Equity Securities and Use of Proceeds 24
Item No. 3 Defaults Upon Senior Securities 24
Item No. 4 Submission of Matters to a Vote of Security Holders 24
Item No. 5 Other Information 24
Item No. 6 Exhibits 25
  Signatures 26
Exhibit 31.1  
  Exhibit 31.2  
  Exhibit 32  

  

 

 

 

PART 1 - FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
CTI Industries Corporation and Subsidiaries
Condensed Consolidated Balance Sheets

 

    September 30, 2017     December 31, 2016  
    (unaudited)          
ASSETS              
Current assets:                
Cash and cash equivalents (VIE $3,000 and $51,000, respectively)   $ 324,712     $ 563,043  
Accounts receivable, (less allowance for doubtful accounts of $127,000 and $137,000, respectively) (VIE $29,000 and $6,000, respectively)     9,481,084       14,838,978  
Inventories, net (VIE $611,000 and $719,000, respectively)     19,348,108       18,348,011  
Prepaid expenses (VIE $39,000 and $18,000, respectively)     665,437       678,689  
Other current assets (VIE $200 and $0, respectively)     675,821       530,669  
                 
Total current assets     30,495,162       34,959,390  
                 
Property, plant and equipment:                
Machinery and equipment (VIE $0 and $0, respectively)     26,892,832       26,348,443  
Building     3,387,323       3,379,636  
Office furniture and equipment (VIE $260,000 and $154,000, respectively)     3,277,226       3,597,158  
Intellectual property     752,044       482,088  
Land     250,000       250,000  
Leasehold improvements     415,549       395,603  
Fixtures and equipment at customer locations     3,302,868       3,302,868  
Projects under construction     102,477       493,859  
      38,380,319       38,249,655  
Less : accumulated depreciation and amortization (VIE $35,000 and $29,000, respectively)     (33,416,436 )     (32,938,267 )
                 
Total property, plant and equipment, net     4,963,883       5,311,388  
                 
Other assets:                
Goodwill (VIE $440,000 and $440,000, respectively)     1,473,176       1,473,176  
Net deferred income tax asset     2,023,781       1,696,690  
Other assets (due from related party $50,000 and $47,000, respectively)     408,428       473,095  
                 
Total other assets     3,905,385       3,642,961  
                 
TOTAL ASSETS   $ 39,364,430     $ 43,913,739  
                 
LIABILITIES AND EQUITY                
Current liabilities:                
Checks written in excess of bank balance   $ 518,076     $ 1,688,675  
Trade payables (VIE $156,000 and $92,000, respectively)     6,101,567       5,861,932  
Line of credit (VIE $356,000 and $408,000, respectively)     8,567,174       11,263,531  
Notes payable - current portion (net discount of $0 and $113,000, respectively) (VIE $0 and $0, respectively)     7,445,091       1,709,220  
Notes payable officers - current portion     -       180,000  
Notes payable affiliates - current portion     10,109       8,141  
Capital Lease - current portion     14,283       40,660  
Accrued liabilities (VIE $147,000 and $140,000, respectively)     2,934,652       3,127,425  
                 
Total current liabilities     25,590,952       23,879,584  
                 
Long-term liabilities:                
Notes payable - affiliates     213,669       218,858  
Notes payable, net of current portion (net discount of $0 and $0, respectively) (VIE $196,000 and $301,000, respectively)     195,722       5,301,491  
Notes payable - officers, subordinated     1,490,332       1,416,138  
Capital Lease     -       4,690  
Deferred gain (non current)     251,372       297,521  
                 
Total long-term debt, net of current portion     2,151,095       7,238,698  
                 
Warrants Payable     -       817,880  
                 
Total long-term liabilities     2,151,095       8,056,578  
                 
Equity:                
CTI Industries Corporation stockholders' equity:                
Preferred Stock -- no par value, 3,000,000 shares authorized, 0 shares issued and outstanding             -  
Common stock - no par value, 15,000,000 shares authorized, 3,568,885 shares issued and 3,525,227 shares outstanding     13,898,494       13,898,494  
Paid-in-capital     2,230,145       2,250,235  
Accumulated earnings     1,580,967       2,323,326  
Accumulated other comprehensive loss     (5,100,978 )     (5,593,878 )
Less: Treasury stock, 43,658 shares     (160,784 )     (160,784 )
                 
Total CTI Industries Corporation stockholders' equity     12,447,844       12,717,393  
                 
Non controlling interest     (825,461 )     (739,816 )
                 
Total Equity     11,622,383       11,977,577  
                 
TOTAL LIABILITIES AND EQUITY   $ 39,364,430     $ 43,913,739  

 

See accompanying notes to condensed consolidated unaudited financial statements

 

  1  

 

 

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2017     2016     2017     2016  
                         
Net Sales   $ 13,225,954     $ 13,476,157     $ 41,397,288     $ 42,831,655  
                                 
Cost of Sales     10,039,044       10,064,066       31,475,520       31,661,039  
                                 
Gross profit     3,186,910       3,412,091       9,921,768       11,170,616  
                                 
Operating expenses:                                
General and administrative     1,923,315       1,808,299       5,691,186       5,470,523  
Selling     861,856       977,928       2,771,150       3,162,083  
Advertising and marketing     454,927       581,143       1,548,709       1,643,852  
Gain on sale of assets     (27,426 )     (27,700 )     (119,127 )     (27,700 )
Other operating income     -       -       (1,416 )     -  
                                 
Total operating expenses     3,212,672       3,339,670       9,890,502       10,248,758  
                                 
(Loss) Income from operations     (25,762 )     72,421       31,266       921,858  
                                 
Other (expense) income:                                
Interest expense     (367,391 )     (358,643 )     (1,100,038 )     (1,074,295 )
Change in fair value of warrants     (3,809 )     47,617       19,999       (179,261 )
Foreign currency loss     (11,430 )     9,663       (92,382 )     77,341  
                                 
Total other expense, net     (382,630 )     (301,363 )     (1,172,421 )     (1,176,215 )
                                 
Net (loss) before taxes     (408,392 )     (228,942 )     (1,141,155 )     (254,357 )
                                 
Income tax expense     (125,678 )     (28,655 )     (313,151 )     (16,804 )
                                 
Net (loss)     (282,714 )     (200,287 )     (828,004 )     (237,553 )
                                 
Less: Net (loss) income attributable to noncontrolling interest     (8,014 )     (19,812 )     (85,645 )     19,089  
                                 
Net loss attributable to CTI Industries Corporation   $ (274,700 )   $ (180,475 )   $ (742,359 )   $ (256,642 )
                                 
Other Comprehensive Income (Loss)                                
Foreign currency adjustment     (260,469 )     (236,133 )     492,900       (840,144 )
Comprehensive Income (Loss)   $ (535,169 )   $ (416,608 )   $ (249,459 )   $ (1,096,786 )
                                 
Basic loss per common share   $ (0.08 )   $ (0.05 )   $ (0.20 )   $ (0.07 )
                                 
Diluted loss per common share   $ (0.08 )   $ (0.05 )   $ (0.20 )   $ (0.07 )
                                 
Weighted average number of shares and equivalent shares of common stock outstanding:                                
Basic     3,641,439       3,541,582       3,641,439       3,541,582  
                                 
Diluted     3,641,439       3,714,239       3,789,081       3,703,732  

 

See accompanying notes to condensed consolidated unaudited financial statements

 

  2  

 

 

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

 

    For the Nine Months Ended September 30,  
    2017     2016  
             
Cash flows from operating activities:                
Net (loss) income   $ (828,004 )   $ (237,553 )
Adjustment to reconcile net income to cash provided by operating activities:                
Depreciation and amortization     1,163,736       1,153,688  
Amortization of debt discount     112,622       125,689  
Change in fair value of warrants     (19,999 )     179,261  
Stock based compensation     -       28,719  
Amortization of deferred gain on sale/leaseback     (84,759 )     -27700  
Provision for losses on accounts receivable     (20,882 )     28,685  
Provision for losses on inventories     94,518       (31,259 )
Deferred income taxes     (409,621 )     (170,653 )
Change in assets and liabilities:                
Accounts receivable     5,864,010       807,687  
Inventories     (324,813 )     (5,597,774 )
Prepaid expenses and other assets     16,362       (77,839 )
Trade payables     (60,770 )     3,461,400  
Accrued liabilities     (272,183 )     102,981  
                 
Net cash provided by (used in) operating activities   $ 5,230,217     $ (254,668 )
                 
Cash flows from investing activities:                
Proceeds from equipment sale-leaseback     -       783,134  
Cash used in investment in subsidiary     -       (87,500 )
Purchases of property, plant and equipment     (735,567 )     (555,961 )
                 
Net cash (used in) provided by investing activities   $ (735,567 )   $ 139,673  
                 
Cash flows from financing activities:                
Change in checks written in excess of bank balance     (1,170,599 )     31,560  
Net change in revolving line of credit     (2,758,809 )     (590,594 )
Proceeds from issuance of long-term debt     -       1,180,000  
Repayment of long-term debt (related parties $0 and $0)     (466,638 )     (652,903 )
Proceeds from issuance of stock     -       638,324  
Cash paid for deferred financing fees     (20,298 )     -  
Contributions received by Variable Interest Entity     -       288,750  
Redemption of Variable Interest Entity members     -       (455,000 )
                 
Net cash (used in) provided by financing activities   $ (4,416,344 )   $ 440,137  
                 
Effect of exchange rate changes on cash     (316,637 )     (47,666 )
                 
Net decrease in cash and cash equivalents     (238,331 )     277,476  
                 
Cash and cash equivalents at beginning of period     563,043       346,404  
                 
Cash and cash equivalents at end of period   $ 324,712     $ 623,880  
                 
                 
Supplemental disclosure of cash flow information:                
Cash payments for interest     934,057       910,414  
Cash payments for taxes     300,000       -  
                 
                 
Supplemental Disclosure of non-cash investing and financing activity                
Exchange of Note Payable for Warrants   $ 797,881     $ -  
Property, Plant & Equipment acquisitions funded by liabilities   $ 19,580     $ 35,012  
Contributed Capital to Clever Container                
Stock     -     $ 122,500  
Debt     -     $ 43,750  
Accounts Receivable     -     $ 183,750  

 

See accompanying notes to condensed consolidated unaudited financial statements

 

  3  

 

 

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Earnings per Share (unaudited)

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2017     2016     2017     2016  
Basic                                
Average shares outstanding:                                
Weighted average number of common shares outstanding     3,641,439       3,541,582       3,641,439       3,541,582  
                                 
Net loss:                                
Net loss attributable to CTI Industries Corporation   $ (274,700 )   $ (180,475 )   $ (742,359 )   $ (256,642 )
                                 
Per share amount   $ (0.08 )   $ (0.05 )   $ (0.20 )   $ (0.07 )
                                 
Diluted                                
Average shares outstanding:                                
Weighted average number of common shares outstanding     3,641,439       3,541,582       3,641,439       3,541,582  
                                 
Effect of dilutive shares     -       172,657       147,642       162,150  
                                 
Weighted average number of shares and equivalent shares of common stock outstanding     3,641,439       3,714,239       3,789,081       3,703,732  
                                 
Net loss:                                
Net loss attributable to CTI Industries Corporation   $ (274,700 )   $ (180,475 )   $ (742,359 )   $ (256,642 )
                                 
Per share amount   $ (0.08 )   $ (0.05 )   $ (0.20 )   $ (0.07 )

 

See accompanying notes to condensed consolidated unaudited financial statements

 

  4  

 

 

CTI Industries Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 - Basis of Presentation

 

The accompanying condensed (a) consolidated balance sheet as of December 31, 2016, which has been derived from audited consolidated financial statements, and (b) the unaudited interim condensed consolidated financial statements have been prepared and, in the opinion of management, contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of comprehensive income and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three months ended September 30, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2017. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2016.

 

Principles of consolidation and nature of operations:

 

The condensed consolidated financial statements include the accounts of CTI Industries Corporation and its wholly-owned subsidiaries, CTI Balloons Limited and CTI Supply, Inc., its majority-owned subsidiaries, Flexo Universal, S. de R.L. de C.V. and CTI Europe gmbH, as well as the accounts of Venture Leasing S. A. de R. L., Venture Leasing L.L.C and Clever Container Company, L.L.C. (the “Company”). The last three entities have been consolidated as variable interest entities. All significant intercompany transactions and accounts have been eliminated in consolidation. The Company (i) designs, manufactures and distributes balloon products throughout the world, (ii) operates systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products, and (iii) distributes vacuum sealing products and home organization products in the United States.

 

Variable Interest Entities (“VIE’s”):

 

The determination of whether or not to consolidate a variable interest entity under U.S. GAAP requires a significant amount of judgment concerning the degree of control over an entity by its holders of variable interest. To make these judgments, management has conducted an analysis of the relationship of the holders of variable interest to each other, the design of the entity, the expected operations of the entity, which holder of variable interests is most “closely associated” to the entity and which holder of variable interests is the primary beneficiary required to consolidate the entity. Upon the occurrence of certain events, management reviews and reconsiders its previous conclusion regarding the status of an entity as a variable interest entity. There are three entities that have been consolidated as variable interest entities.

 

  5  

 

 

Use of estimates:

 

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue and expenses during the reporting period in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include reserves for doubtful accounts, reserves for the lower of cost or market of inventory, reserves for deferred tax assets and recovery value of goodwill.

 

Earnings per share:

 

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during each period.

 

Diluted earnings per share is computed by dividing the net income by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

 

As of September 30, 2017 and 2016, shares to be issued upon the exercise of options and warrants aggregated 205,144 and 288,048, respectively. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended September 30, 2017 and 2016 were 281,819 and 0, respectively. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the nine months ended September 30, 2017 and 2016 were 178,350 and 0, respectively.

 

Significant Accounting Policies:

 

The Company’s significant accounting policies are summarized in Note 2 of the Company’s consolidated financial statements for the year ended December 31, 2016. There were no significant changes to these accounting policies during the three and nine months ended September 30, 2017.

 

Reclassification:

 

Certain 2016 amounts have been reclassified to conform to the 2017 presentation. (See footnote regarding ASU 2015-17.)

 

Recent Accounting Pronouncements:

 

In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern . This guidance amended the existing requirements for disclosing information about an entity’s ability to continue as a going concern, requires management to assess an entity’s ability to continue as a going concern and then to provide related disclosure in certain circumstances. This guidance is effective for annual reporting periods ending after December 2016 and for annual and interim reporting periods thereafter. See Note 2 for management’s assessment of its ability to continue as a going concern.

 

  6  

 

 

In 2014, the FASB issued guidance on revenue recognition, which provides for a single five-step model to be applied to all revenue contracts with customers. The guidance also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. The guidance provides an option to use either a retrospective approach or a cumulative effect adjustment approach to implement the guidance. In 2015, the FASB issued a deferral of the effective date of the guidance to 2018, with early adoption permitted in 2017. In 2016, the FASB issued final amendments clarifying the implementation guidance for principal versus agent considerations, identifying performance obligations and the accounting of intellectual property licenses. In addition, the FASB introduced practical expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes. We are currently evaluating the impact of this guidance on our financial statements and the timing of adoption, and have not yet selected a transition approach.

 

In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes , to eliminate the current requirements to classify deferred income tax assets and liabilities between current and noncurrent. To simplify the presentation of deferred income taxes, the amendments in this update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. For public business entities, the amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. The Company has adopted the standard and the impact to our consolidated financial statements for the period ending September 30, 2017 is a reclassification of $779,000 in deferred tax assets to noncurrent, and a reclassification of $773,000 in deferred tax assets to noncurrent for the period ending December 31, 2016.

 

In February 2016, the FASB issued ASU 2016-02, Leases ( Topic 842), aimed at making leasing activities more transparent and comparable. The new standard requires substantially all leases be recognized by lessees on their balance sheet as a right-of-use asset and corresponding lease liability, including today’s operating leases. For public business entities, the standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. When the standard becomes effective, we expect that our property, plant and equipment will increase significantly due to the addition of assets under lease and the lease liabilities will correspondingly increase. There is not expected to be a significant impact on the income statement.

 

  7  

 

 

On August 26, 2016, the FASB issued Accounting Standards Update No. 2016-15, Statement of Cash Flows (Topic 230) , a consensus of the FASB’s Emerging Issues Task Force (“ASU 2016-15”). The new guidance amends Accounting Standards Codification No. 230 (“ASC 230”) to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. ASC 230 lacks consistent principles for evaluating the classification of cash payments and receipts in the statement of cash flows. This has led to diversity in practice and, in certain circumstances, financial statement restatements. Therefore, the FASB issued the ASU 2016-15 with the intent of reducing diversity in practice with respect to eight types of cash flows. ASU 2016-15 is effective for annual and interim periods in fiscal years beginning after December 15, 2017, and is effective for the Company for the year ending December 31, 2018. The Company is currently evaluating the impact that the implementation of this standard will have on the Company’s consolidated financial statements.

 

Note 2 – Liquidity and Going Concern

 

The Company’s primary sources of liquidity are cash and cash equivalents as well as availability under the Credit Agreement with BMO Harris. The Company has historically used availability under this revolving credit facility to fund operations.

 

For the nine months ended September 30, 2017, the Company generated net cash from operating activities in the amount of $5,230,000, although the Company did incur a loss for the quarter ended September 30, 2017 of $275,000 and for the nine months ended September 30, 2017 of $742,000.

 

Assuming a continuation of the revolving credit under the Credit Agreement, the Company has forecast a profit for the fourth quarter of the year, which is expected to generate sufficient cash flow for the Company to meet its current obligations.

 

As of September 30, 2017, the Company was in compliance with all of the financial covenants under the Credit Agreement with Harris Bank and the Note and Warrant Purchase Agreement with BMO Private Equity (U.S.), Inc. (“BMO Private Equity”).

 

As of September 30, 2017, the Company had total borrowings outstanding under the Credit Agreement with BMO Harris of $9,852,000, including $8,211,000 on the revolving credit loan and $1,641,000 on the mortgage facility. In addition, the balance of the indebtedness of the Company to BMO Private Equity as of September 30, 2017 was approximately $5,965,000.

 

The obligations of the Credit Agreement to BMO Harris were to mature on July 17, 2017. The obligations of the Note and Warrant Purchase Agreement among the Company and BMO Equity are to mature on January 18, 2018.

 

By Amendment to the Credit Agreement dated July 18, 2017, BMO Harris agreed to extend the maturity date of the agreement to October 18, 2017. BMO Equity consented to this extension in exchange for a fee and for the right to exercise at any time its put of warrants issued to it under the Note and Warrant Purchase Agreement. The extension provides retention by the Company of a consultant to advise as to planning, forecasting, cost management and financing.

 

On August 17, 2017, BMO Equity exercised its put on the warrants and the Company issued to BMO Equity a Warrant Conversion Note in the amount of $797,881 for the purchase of the warrants. The principal balance of the Warrant Conversion Note, plus accrued and unpaid interest thereon, is payable on January 18, 2018. The principal balance of the Warrant Conversion Note accrues interest at the rate of 11.5% per annum compounded daily.

 

On October 17, 2017, the Company and BMO Harris entered into Amendment No. 11 to the Credit Agreement in which (i) the Company acknowledged its indebtedness to the Bank for a Mortgage Loan balance in the amount of $1,664,456 and for a balance of $8,211,467 with respect to the Revolving Loans, (ii) the maturity date on the Mortgage Loan and the Revolving Credit were extended to November 30, 2017, and (iii) the Bank provided a temporary over advance line of $1,000,000 for the period from October 17, 2017 through November 30, 2017. Amendment No. 11 included certain additional covenants including that, on or before October 20, 2017, the Company would deliver to the Bank an executed letter of intent from a third-party financial institution providing for refinancing and payment of the Company’s debt obligations to the Bank. Also, on October 17, 2017, the Registrant entered into Amendment No. 6 to the Note and Warrant Agreement among Registrant and BMO Private Equity (U.S.) Inc. (BMO Private Equity). In the Amendment, (i) the Company acknowledged its indebtedness to BMO Private Equity for a subordinated note in the principal amount of $5,000,000 and, for a note issued in connection with the conversion by BMO Private Equity of warrants, in the amount of $815,139, (ii) BMO Private Equity agreed to defer payment of interest due on October 2, 2017 in the amount of $150,139 to December 1, 2017. Amendment No. 6 includes covenants similar to that of Amendment No. 11 with the Bank.

 

  8  

 

 

On October 19, 2017, the Company delivered to the Bank and to BMO Equity an executed non-binding Preliminary Memorandum of Terms and Conditions (“Preliminary Term Sheet”) from a financing institution providing for an aggregate of up to $24,000,000 in senior secured financing to (i) refinance existing senior bank and mezzanine debt, (ii) fund certain capital expenditures and (iii) provide for ongoing working capital needs of Registrant. The Preliminary Term Sheet is non-binding and is subject to diligence and to the execution of a definitive agreement.

 

Management’s Plans.

 

Management is engaged in efforts to obtain re-financing of its obligations to BMO Harris and BMO Private Equity, is in accordance with the Preliminary Term Sheet and is engaged in a diligence and loan documentation process. While no assurance can be given that the re-financing will be completed, management has a reasonable expectation that both the re-financing will be completed and that the Company will continue as a going concern.

 

Management is also engaged in efforts to implement cost and operational improvements and to fulfill strong order flow in order to achieve profitable operations for the fourth quarter.

 

Note 3 - Stock-Based Compensation; Changes in Equity

 

The Company has adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their grant-date fair values.

 

The Company has applied the Black-Scholes model to value stock-based awards and issued warrants related to notes payable. That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of our common stock. The risk-free rate of interest is the related U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The dividend yield on our common stock is estimated to be 0%, as the Company did not issue dividends during 2017 and 2016. The expected volatility is based on historical volatility of the Company’s common stock.

 

The Company’s net loss for the three months ended September 30, 2017 and 2016 includes approximately $2,000 and $5,000, respectively, of compensation costs related to share based payments. The Company’s net loss for the nine months ended September 30, 2017 and 2016 includes approximately $12,000 and $29,000, respectively, of compensation costs related to share based payments. As of September 30, 2017, there is $13,000 of unrecognized compensation expense related to non-vested stock option grants and stock grants. We expect approximately $2,000 of additional stock-based compensation expense to be recognized over the remainder of 2017, $7,000 to be recognized during 2018, $3,000 to be recognized during 2019 and $1,000 to be recognized during 2020.

 

As of September 30, 2017, the Company had three stock-based compensation plans pursuant to which stock options were, or may be, granted. The Plans provide for the award of options, which may either be incentive stock options (“ISOs”) within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended (the “Code”) or non-qualified options (“NQOs”) which are not subject to special tax treatment under the Code, as well as for stock grants.

 

  9  

 

 

On April 10, 2009, the Board of Directors approved for adoption, and on June 5, 2009, the shareholders of the Corporation approved, a 2009 Stock Incentive Plan (“2009 Plan”). The 2009 Plan authorizes the issuance of up to 250,000 shares of stock or options to purchase stock of the

Company (including cancelled shares reissued under the plan.) As of September 30, 2017, options for 250,000 shares had been granted and options for 143,094 shares remain outstanding.

 

A summary of the Company’s stock option activity and related information is as follows:

 

    Shares
under
Option
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual Life
    Aggregate
Intrinsic
Value
 
Balance at December 31, 2016     143,094     $ 5.22       2.9     $ 89,494  
Granted     -       -       -       -  
Cancelled/Expired     14,625       5.14       -       -  
Exercised     -       -       -       -  
Outstanding at September 30, 2017     128,469     $ 5.23       1.3     $ 0  
                                 
Exercisable at September 30, 2017     100,788     $ 5.21       0.8     $ 0  

 

On July 17, 2012, the Company entered into a Note and Warrant Purchase Agreement with BMO Private Equity (U.S.), Inc. (“BMO Equity”) pursuant to which (i) BMO Equity advanced to the Company the sum of $5 million and (ii) the Company issued to BMO Equity a warrant to purchase up to Four Percent (4%) of the outstanding shares of common stock of the Company on a fully-diluted basis (140,048 shares of common stock of the Company) at the price of One Cent ($0.01) per share. The term of the loan provided for in this Agreement is five and a half years. Interest is payable on the outstanding balance of the loan at the rate of 11.5% per annum. As of September 30, 2017, the Company was in compliance with all of the financial covenants under the Note and Warrant Purchase Agreement.

 

On July 29, 2016, the Company and certain accredited investors entered into a Securities Purchase Agreement wherein the investors purchased 152,850 shares of common stock of the Company at a price of $6.00 per share. As additional consideration for the purchases of the shares in the offering, each investor received, with each share of common stock purchased, one-half of a warrant, with one warrant entitling the investor to purchase one share of the Company’s common stock at the price of $7.00. The warrants are exercisable between six months and three years from the investment date. As a result of the completion of the sale under the Purchase Agreement, warrants to purchase 76,675 shares of common stock at $7.00 per share were issued.

 

In addition to the Purchase Agreement, the Company and each of the investors entered into a Registration Rights Agreement pursuant to which the Company agreed to file a Registration Statement with the SEC to register the common stock sold to the investors.

 

  10  

 

 

A summary of the Company’s stock warrant activity and related information is as follows:

  

    Shares
under
Warrant
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
    Aggregate
Intrinsic
Value
 
Balance at December 31, 2016     216,723     $ 2.48       4.49     $ 817,880  
Granted     -       -       -       -  
Cancelled     -       -       -       -  
Exercised     140,048       0.01       -     $ 642,820  
Outstanding at September 30, 2017     76,675     $ 7.00       1.8     $ -  
                                 
Exercisable at September 30, 2017     76,675     $ 7.00       1.8     $ -  

 

A summary of the Company’s stock option activity by grant date as of September 30, 2017 is as follows:

 

    Options Outstanding     Options Vested  
Options by
Grant Date
  Shares     Weighted
Avg.
    Remain.
Life
    Intrinsic
Val
    Shares     Weighted
Avg.
    Remain.
Life
    Intrinsic Val  
Dec 2005     -       -       -       -       -       -       -       -  
Dec 2010     -       -       -       -       -       -       -       -  
Jan 2011     -       -       -       -       -       -       -       -  
Nov 2012     79,000     $ 5.17       0.2     $ 0       79,000     $ 5.17       0.2     $ 0  
Nov 2013     5,000     $ 5.75       1.1     $ 0       4,000     $ 5.75       1.1     $ 0  
Dec 2015     44,469     $ 5.29       3.3     $ 0       17,788     $ 5.27       3.3     $ 0  
TOTAL     128,469     $ 5.23       1.3     $ 0       100,788     $ 5.21       0.8     $ 0  

 

The aggregate intrinsic value in the tables above represents the total pre-tax intrinsic value (the difference between the closing price of the Company’s common stock on the last trading day of the quarter ended September 30, 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the holders exercised their options on September 30, 2017.

 

Note 4 - Legal Proceedings

 

The Company is party to certain claims or actions arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the resolution of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

 

Note 5 - Other Comprehensive Income

 

In the three and nine months ended September 30, 2017, the Company incurred other comprehensive loss and income of approximately ($260,000) and $493,000, respectively, all from foreign currency translation adjustments.

 

The following table sets forth the accumulated balance of other comprehensive income and each component.

 

  11  

 

 

    Foreign Currency Items     Total
Accumulated Other
Comprehensive Income
 
             
Beginning balance as of January 1, 2017   $ (5,593,878 )   $ (5,593,878 )
                 
Current period change, net of tax     492,900       492,900  
                 
Ending Balance as of September 30, 2017     (5,100,978 )     (5,100,978 )

 

Note 6 - Inventories, Net

 

   

September 30,

2017

    December 31,
2016
 
Raw materials   $ 3,485,026     $ 3,310,310  
Work in process     2,873,071       1,942,600  
Finished goods     13,881,057       13,889,328  
Allowance for excess quantities     (891,046 )     (794,227 )
Total inventories   $ 19,348,108     $ 18,348,011  

 

Note 7 - Geographic Segment Data

 

The Company has determined that it operates primarily in one business segment that designs, manufactures and distributes film and film related products for use in packaging, storage and novelty balloon products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic area is as follows:

 

  12  

 

 

    Net Sales to Outside Customers     Net Sales to Outside Customers  
    For the Three Months Ended     For the Nine Months Ended  
    September 30,     September 30,  
    2017     2016     2017     2016  
                         
United States   $ 9,039,000     $ 10,392,000     $ 30,165,000     $ 33,527,000  
Europe     1,261,000       761,000       3,125,000       1,927,000  
Mexico     2,627,000       1,723,000       6,605,000       5,438,000  
United Kingdom     299,000       600,000       1,502,000       1,940,000  
                                 
    $ 13,226,000     $ 13,476,000     $ 41,397,000     $ 42,832,000  

 

    Total Assets at  
    September 30,     December 31,  
    2017     2016  
             
United States   $ 27,689,000     $ 33,108,000  
Europe     3,176,000       2,418,000  
Mexico     9,020,000       7,064,000  
United Kingdom     847,000       1,324,000  
                 
    $ 40,732,000     $ 43,914,000  

 

Note 8 - Concentration of Credit Risk

 

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company's customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management's expectations. During the three and nine months ended September 30, 2017 and 2016, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales, respectively. Sales to these customers for the three months ended September 30, 2017 and 2016 are as follows:

 

    Three Months Ended     Three Months Ended  
    September 30, 2017     September 30, 2016  
Customer   Net Sales     % of Net
Sales
    Net Sales     % of Net
Sales
 
Customer A   $ 3,195,000       24.2 %   $ 3,088,000       22.9 %
Customer B   $ 2,283,000       17.3 %   $ 3,070,000       22.8 %

 

  13  

 

 

    Nine Months Ended     Nine Months Ended  
    September 30, 2017     September 30, 2016  
Customer   Net Sales     % of Net
Sales
    Net Sales     % of Net
Sales
 
Customer A   $ 11,489,000       27.8 %   $ 11,859,000       27.7 %
Customer B   $ 6,457,000       15.6 %   $ 7,870,000       18.4 %

 

As of September 30, 2017, the total amounts owed to the Company by these customers were approximately $1,491,000 or 19.6%, and $1,631,000 or 21.5%, of the Company’s consolidated net accounts receivable, respectively. The amounts owed at September 30, 2016 by these customers were approximately $1,411,000 or 13.9%, and $2,653,000 or 26.1% of the Company’s consolidated net accounts receivable, respectively.

 

Note 9 - Related Party Transactions

 

Stephen M. Merrick, President of the Company, is of counsel to the law firm of Vanasco Genelly and Miller PC which provides legal services to the Company. Legal fees paid by the Company to this firm for the three months ended September 30, 2017 and 2016, respectively, were $29,000 and $57,000. Legal fees paid by the Company to this firm for the nine months ended September 30, 2017 and 2016, respectively, were $93,000 and $128,000.

 

Interest payments have been made or accrued to John H. Schwan, Chief Executive Officer of the Company, for loans made to the Company. During the three months ended September 30, 2017 and 2016, these interest accruals totaled $24,000 and $23,000, respectively. During the nine months ended September 30, 2017 and 2016, these interest accruals totaled $59,000 and $69,000, respectively.

 

John H. Schwan, Chief Executive Officer of the Company, through an investment entity, and Stephen M. Merrick, President of the Company, also through an investment entity own, in aggregate, a 50% interest in Clever Container Company L.L.C., an Illinois limited liability company (“Clever Container”). During the three months ended September 30, 2017 and 2016, Clever Container purchased various products from the Company in the amount of $262,000 and $191,000, respectively. During the nine months ended September 30, 2017 and 2016, Clever Container purchased various products from the Company in the amount of $716,000 and $669,000, respectively. As of September 30, 2017 and 2016, the balance of accounts receivable from Clever Container to the Company were $924,000 and $192,000, respectively. The Company owns a 28.5% interest in Clever Container.

 

Note 10 - Derivative Instruments; Fair Value

 

The following tables represents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

 

  14  

 

 

    Amount as of                    
Description   9/30/2017     Level 1     Level 2     Level 3  
                         
Warrant Liability   $ -       -     $ -       -  
                                 
    $ -       -     $ -       -  

 

    Amount as of                    
Description   12/31/2016     Level 1     Level 2     Level 3  
                         
Warrant Liability   $ 818,000       -     $ 818,000       -  
                                 
    $ 818,000             $ 818,000          

 

Note 11 – Subsequent Events

 

On November 9, 2017, the Company and S.C. Johnson & Son Inc. entered into a Fourth Amendment to the Trademark License Agreement among them dated December, 2011, extending the term of the Trademark License Agreement to December 31, 2019.

 

  15  

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Forward Looking Statements

 

This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this quarterly report to conform such statements to actual results or to changes in our opinions or expectations.

 

Overview

 

We produce film products for novelty, packaging and container applications. These products include foil balloons, latex balloons and related latex toy products, films for packaging and custom product applications, and flexible containers for packaging and consumer storage applications. We produce all of our film products for packaging, container applications and foil balloons at our plant in Lake Barrington, Illinois. We produce all of our latex balloons and latex products at our facility in Guadalajara, Mexico. Substantially all of our film products for packaging and custom product applications are sold to customers in the United States. We market and sell our novelty items and flexible containers for consumer use in the United States, Mexico, Latin America, and Europe. We also market and sell vacuum sealing machines which we purchase from a supplier and we market and sell home organizing and container products.

 

Results of Operations

 

Net Sales . For the three months ended September 30, 2017, net sales were $13,226,000 compared to net sales of $13,476,000 for the same period of 2016, a decrease of 1.9%. For the quarters ended September 30, 2017 and 2016, net sales by product category were as follows:

 

  16  

 

 

    Three Months Ended  
    September 30, 2017     September 30, 2016  
    $     % of     $     % of  
Product Category   (000) Omitted     Net Sales     (000) Omitted     Net Sales  
                         
Foil Balloons     5,767       44 %     6,178       46 %
                                 
Latex Balloons     2,620       20 %     1,875       14 %
                                 
Vacuum Sealing Products     2,397       18 %     2,594       19 %
                                 
Film Products     658       5 %     1,137       8 %
                                 
Other Sales     1,784       13 %     1,692       13 %
                                 
Total     13,226       100 %     13,476       100 %

 

For the nine months ended September 30, 2017, net sales were $41,397,000 compared to net sales of $42,382,000 for the same period of 2016, a decrease of 3.4%. For the nine months ended September 30, 2017 and 2016, net sales by product category were as follows:

 

    Nine Months Ended  
    September 30, 2017     September 30, 2016  
    $     % of     $     % of  
Product Category   (000) Omitted     Net Sales     (000) Omitted     Net Sales  
                         
Foil Balloons     21,447       52 %     20,540       48 %
                                 
Latex Balloons     6,969       17 %     6,182       14 %
                                 
Vacuum Sealing Products     5,668       14 %     7,362       17 %
                                 
Film Products     2,194       5 %     3,508       8 %
                                 
Other Sales     5,119       12 %     5,240       13 %
                                 
Total     41,397       100 %     42,832       100 %

 

Foil Balloons . During the three months ended September 30, 2017, revenues from the sale of foil balloons decreased by 6.6% compared to the prior year period from $6,178,000 to $5,767,000. For the nine months ended September 30, 2017, revenues from the sale of foil balloons increased by 4.4% compared to the prior year period, from $20,540,000 to $21,447,000. In that period, foil balloon sales to our largest customer decreased to $11,489,000 from $9,958,000 in the first three quarters of 2016. However, during that nine month period, sales of foil balloons to other customers increased to $10,818,000 from $8,715,000 for the same period last year. These increased sales represent certain new customers but principally increases in sales to significant existing customers in each of the United States, Mexico, the United Kingdom and Europe.

 

Latex Balloons. During the three months ended September 30, 2017, revenues from the sale of latex balloons increased by 39.8% compared to the prior year period, from $1,875,000 to $2,620,000. During the nine months ended September 30, 2017, revenues from the sale of latex balloons increased by 12.7% compared to the prior year period from $6,182,000 to $6,969,000. Substantially all of the increases in sales of latex balloons during the third quarter and the nine month period have been sales by Flexo Universal to existing and new customers principally in Mexico. These include sales to several major chains and to distributors.

 

  17  

 

 

Vacuum Sealing Products . During the three months ended September 30, 2017, revenues from the sale of pouches and vacuum sealing machines decreased by 7.6% compared to the prior year, from $2,594,000 to $2,397,000. During the nine months ended September 30, 2017, revenues from the sale of pouches and vacuum sealing machines decreased by 23.0% compared to the prior year from $7,362,000 to $5,668,000. We believe that sales were affected during both the first and second quarters by the selloff of excess inventory of vacuum sealing machines held by a principal customer due to a sales promotion the customer implemented during the fourth quarter of 2016 for which a large quantity of machines were purchased.

 

Films . During the three months ended September 30, 2017, revenues from the sale of laminated film products decreased by 42.2% compared to the prior year period from $1,137,000 to $658,000. During the nine months ended September 30, 2017, revenues from the sale of laminated film products decreased by 37.4% compared to the prior year period from $3,508,000 to $2,194,000. Virtually all of the sales of this product line were to a single long-term customer. Sales to the customer have declined due to the elimination of one product previously purchased. However, we continue to maintain a long term relationship with the customer with respect to other products.

 

Other Revenues . During the three months ended September 30, 2017, revenues from the sale of various other products increased by 5.4% to $1,784,000 compared to revenues from other products in the same period in 2016 of $1,692,000. During the nine months ended September 30, 2017, revenues from the sale of various other products decreased by 2.3% to $5,119,000 compared to revenues from other products in the same period in 2016 of $5,240,000. The revenues from the sale of other products during 2017 include (i) sales of a line of “Candy Blossoms” and “Candy Loons” consisting of candy and small inflated balloons sold in small containers, (ii) the sale of accessories and supply items related to balloon products, (iii) sales by Clever Container Company, L.L.C. which engages in the direct sale of container and organizing products through a network of independent distributors and (iv) sales of party goods in Mexico by Flexo Universal.

 

Sales to a limited number of customers continue to represent a large percentage of our net sales.

 

The table below illustrates the impact on sales of our top three and ten customers for the three and nine months ended September 30, 2017 and 2016.

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    % of Sales     % of Sales  
    2017     2016     2017     2016  
                         
Top 3 Customers     47.5 %     53.9 %     48.5 %     54.0 %
                                 
Top 10 Customers     66.1 %     70.0 %     65.4 %     68.3 %

 

  18  

 

 

During the three and nine months ended September 30, 2017, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three months ended September 30, 2017 were $3,195,000 or 24.2%, and $2,283,000 or 17.3%, of consolidated net sales, respectively. Sales to these customers for the three months ended September 30, 2016 were $3,088,000 or 22.9%, and $3,070,000 or 22.8%, of consolidated net sales, respectively. Sales to these customers for the nine months ended September 30, 2017 were $11,489,000 or 27.8%, and $6,457,000 or 15.6%, of consolidated net sales, respectively. Sales to these customers for the nine months ended September 30, 2016 were $11,859,000 or 27.7%, and $7,870,000 or 18.4%, of consolidated net sales, respectively. The amounts owed at September 30, 2017 by these customers were $1,491,000 or 19.6%, and $1,631,000 or 21.5%, of the Company’s consolidated net accounts receivable, respectively. As of September 30, 2016, the total amounts owed to the Company by these customers were $1,411,000 or 15.7%, and $2,653,000 or 29.4% of the Company’s consolidated net accounts receivable, respectively.

 

Cost of Sales . During the three months ended September 30, 2017, the cost of sales represented 75.9% of net sales compared to 74.7% for the three months ended September 30, 2016. During the nine months ended September 30, 2017, the cost of sales represented 76.0% of net sales compared to 73.9% for the nine months ended September 30, 2016. The decline in gross margin both in the third quarter and for the nine month period is attributable principally to changes in the mix of products sold. Gross margin rates on latex balloon products are lower than certain of our other products so the increase in latex product sales in these periods have affected overall gross margins. Vacuum sealing products generally carry higher gross margins so the decline in sales of that line has tended to reduce the overall gross margin rate. We did not experience significant changes in the cost of raw materials or direct labor during the period.

 

General and Administrative . During the three months ended September 30, 2017, general and administrative expenses were $1,923,000 or 14.5% of net sales, compared to $1,808,000 or 13.4% of net sales for the same period in 2016. During the nine months ended September 30, 2017, general and administrative expenses were $5,691,000 or 13.7% of net sales, compared to $5,471,000 or 12.8% of net sales for the same period in 2016. Some elements of general and administrative costs have declined during the third quarter and the nine month period ended September 30, 2017. These include items incorporated in our cost reduction program, in particular salaries (reduced by over $200,000 over the nine months.) However, we incurred additional costs related to our financing, including consulting fees of $184,000 for the third quarter and $316,000 for the nine months ended September 30, 2017 and legal fees of $54,000 for the third quarter and $138,000 for the nine month period.

 

We have initiated a program in which we expect to achieve overall reductions in general and administrative, selling, marketing and related expenses at the rate of at least $2.4 million on an annualized basis. Some of these expense reductions are reflected in the third quarter and will be reflected in the fourth quarter and throughout 2018.

 

Selling . During the three months ended September 30, 2017, selling expenses were $862,000 or 6.5% of net sales, compared to $978,000 or 7.3% of net sales for the same period in 2016. During the nine months ended September 30, 2017, selling expenses were $2,771,000 or 6.7% of net sales, compared to $3,162,000 or 7.4% of net sales for the same period in 2016. The reduction in selling expenses reflects a reduction in salary expenses and service fees.

 

Advertising and Marketing . During the three months ended September 30, 2017, advertising and marketing expenses were $455,000 or 3.4% of net sales for the period, compared to $581,000 or 4.3% of net sales for the same period of 2016. During the nine months ended September 30, 2017, advertising and marketing expenses were $1,549,000 or 3.7% of net sales for the period, compared to $1,644,000 or 3.8% of net sales for the same period of 2016. The reduction reflects principally the elimination of a consulting expense as of June 30, 2017 which totals $133,000 to date.

 

  19  

 

 

Other Income (Expense) . During the three months ended September 30, 2017, the Company incurred interest expense of $367,000, compared to interest expense during the same period of 2016 in the amount of $359,000. During the nine months ended September 30, 2017, the Company incurred interest expense of $1,100,000, compared to interest expense during the same period of 2016 in the amount of $1,074,000. In addition to interest expense, there is a variable charge relating to the change in value of our outstanding warrants issued in connection with our mezzanine loan by reason of change in market price of our common stock. The amount of that change was $4,000 in the third quarter of 2017, compared to ($48,000) in the third quarter of 2016.

 

For the three months ended September 30, 2017, the Company had a foreign currency transaction loss of $11,000 compared to a foreign currency transaction gain of $10,000 during the same period of 2016. For the nine months ended September 30, 2017, the Company had a foreign currency transaction loss of $92,000 compared to a foreign currency transaction gain of $77,000 during the same period of 2016.

 

Income Taxes . For the three months ended September 30, 2017, the Company reported a consolidated income tax benefit of $126,000, compared to a consolidated income tax benefit of $29,000 for the same period of 2016. For the nine months ended September 30, 2017, the Company reported a consolidated income tax benefit of $313,000, compared to a consolidated income tax expense of $4,000 for the same period of 2016. For the nine months ended September 30, 2017, this income tax expense was composed of an income tax benefit in the United States, income tax expense in Mexico of Flexo Universal, our Mexican subsidiary, an income tax benefit in the United Kingdom of CTI Balloons Limited, our United Kingdom subsidiary and income tax expense in Europe of CTI Europe gmbH, our Germany subsidiary.

 

Net Income. For the three months ended September 30, 2017, the Company had net loss of ($275,000) or ($0.08) per share (basic and diluted,) compared to net loss of ($180,000) for the same period of 2016 or ($0.05) per share (basic and diluted.) For the nine months ended September 30, 2017, the Company had net loss of ($742,000) or ($0.20) per share (basic and diluted,) compared to net loss of ($257,000) for the same period of 2016 or ($0.07) per share (basic and diluted.) For the nine months ended September 30, 2017, the Company had income from operations of $38,000 compared to income from operations during the same period in 2016 of $922,000.

 

Financial Condition, Liquidity and Capital Resources

 

Cash Flow Items.

 

Operating Activities . During the nine months ended September 30, 2017, net cash provided by operations was $5,230,000, compared to net cash used in operations during the nine months ended September 30, 2016 of $255,000.

 

  20  

 

 

Significant changes in working capital items during the nine months ended September 30, 2017 included:

 

· A decrease in accounts receivable of $5,864,000 compared to a decrease in accounts receivable of $808,000 in the same period of 2016.
· An increase in inventory of $325,000 compared to an increase in inventory of $5,598,000 in 2016.
· A decrease in trade payables of $61,000 compared to an increase in trade payables of $3,461,000 in 2016.
· A decrease in accrued liabilities of $272,000 compared to an increase in accrued liabilities of $107,000 in 2016.

 

Investing Activity. During the nine months ended September 30, 2017, cash used in investing activity was $736,000, compared to cash provided by investing activity for the same period of 2016 in the amount of $140,000. Activity consisted principally of investment in equipment and equipment maintenance.

 

Financing Activities . During the nine months ended September 30, 2017, cash used in financing activities was $4,416,000 compared to cash provided by financing activities for the same period of 2016 in the amount of $440,000. Financing activity consisted principally of reduction in the balances of revolving and long term debt.

 

Liquidity, Capital Resources and Going Concern . The Company’s liquidity is dependent significantly on its bank financing and the Company relies on its revolving line of credit to maintain liquidity. On April 29, 2010, the Company entered into a Credit Agreement with BMO Harris Bank N.A. (“BMO Harris”). Under the Credit Agreement, BMO Harris agreed to provide loans and credits to the Company in the aggregate maximum amount of $14,417,000. The arrangement included:

 

i. A revolving credit line up to a maximum amount of $9,000,000 based upon a borrowing base of 85% of eligible receivables and 60% of eligible inventory (up to a maximum of $5,000,000);
ii. A mortgage loan in the principal amount of $2,333,350, amortized over 25 years;
iii. A term loan in the principal amount of $583,333 maturing in monthly principal installments of $58,333; and
iv. An equipment loan commitment in the amount of up to $2,500,000 providing for loan advances from time to time until April 29, 2012 based upon 100% of the purchase price of equipment purchased, the loans to be amortized on a five year basis commencing April 29, 2012.

 

The Credit Agreement included various representations, warranties and covenants of the Company, including various financial covenants.

 

The Credit Agreement, as amended, provides that the outstanding balance of all loans under the agreement will bear interest with reference to a base rate or, at the option of the Company, with reference to an adjusted LIBOR. At September 30, 2017, the effective rate on the outstanding loan balances was 4.5%.

 

As of September 30, 2017, the outstanding balances on the loans with BMO Harris were: (i) revolving line of credit, $8,211,000, (ii) mortgage loan, $1,641,000, and (iii) equipment loan, $0.

 

  21  

 

 

On July 17, 2012, the Company entered into Amendment Number 3 to the Credit Agreement among the Company and BMO Harris pursuant to which (i) the amount of the loan commitment on the revolver loan of BMO Harris was increased from $9 million to $12 million, (ii) BMO Harris consented to a transaction among the Company and BMO Private Equity (U.S.), Inc. (“BMO Equity”) and (iii) the term of credit and loans to the Company provided in the Credit Agreement and BMO Harris was extended to July 17, 2017. The loans subject to the Credit Agreement originally matured on July 17, 2017 and have been extended as noted below.

 

On July 17, 2012, the Company entered into a Note and Warrant Purchase Agreement with BMO Equity pursuant to which (i) BMO Equity advanced to the Company the sum of $5 million and (ii) the Company issued to BMO Equity a warrant to purchase up to Four Percent (4%) of the outstanding shares of common stock of the Company on a fully-diluted basis (140,048 shares of common stock of the Company) at the price of One Cent ($0.01) per share. Interest is payable on the outstanding balance of the loan at the rate of 11.5% per annum. The loan matures on January 17, 2018.

 

The Note and Warrant Purchase Agreement included provisions for:

 

(i)       a closing fee of $100,000

 

(ii)       payment of the principal amount in five and a half years with optional prepayment subject to certain prepayment premiums;

 

(iii)       security for the note obligations in all assets of the Company junior to the security interest of BMO Harris;

 

(iv)       various representations and warranties and covenants of the Company;

 

(v)       financial covenants including an applicable senior leverage ratio, fixed charge coverage ratio and tangible net worth amount.

 

At September 30, 2017, the Company had cash balances of $325,000 compared to cash balances of $624,000 for the same period of 2016.

 

  22  

 

 

Also at September 30, 2017, the Company had a working capital balance of $4,904,000 compared to a working capital balance of $11,080,000 on December 31, 2016.

 

Further, as of September 30, 2017, the Company was in compliance with all of the financial covenants under the Credit Agreement and the Note and Warrant Purchase Agreement.

 

As of September 30, 2017, the Company had total borrowings outstanding under the Credit Agreement with BMO Harris of $9,852,000, including $8,211,000 on the revolving credit loan and $1,641,000 on the mortgage facility. In addition, the balance of the indebtedness of the Company to BMO Private Equity as of September 30, 2017 was approximately $5,965,000.

 

The obligations of the Credit Agreement to BMO Harris were to mature on July 17, 2017. The obligations of the Note and Warrant Purchase Agreement among the Company and BMO Equity are to mature on January 18, 2018.

 

By Amendment to the Credit Agreement dated July 18, 2017, BMO Harris agreed to extend the maturity date of the agreement to October 18, 2017. BMO Equity consented to this extension in exchange for a fee and for the right to exercise at any time its put of warrants issued to it under the Note and Warrant Purchase Agreement. The extension provides retention by the Company of a consultant to advise as to planning, forecasting, cost management and financing.

 

On August 17, 2017, BMO Equity exercised its put on the warrants and the Company issued to BMO Equity a Warrant Conversion Note in the amount of $797,881 for the purchase of the warrants. The principal balance of the Warrant Conversion Note, plus accrued and unpaid interest thereon, is payable on January 18, 2018. The principal balance of the Warrant Conversion Note accrues interest at the rate of 11.5% per annum compounded daily.

 

On October 17, 2017, the Company and BMO Harris entered into Amendment No. 11 to the Credit Agreement in which (i) the Company acknowledged its indebtedness to the Bank for a Mortgage Loan balance in the amount of $1,664,456 and for a balance of $8,211,467 with respect to the Revolving Loans, (ii) the maturity date on the Mortgage Loan and the Revolving Credit were extended to November 30, 2017, and (iii) the Bank provided a temporary over advance line of $1,000,000 for the period from October 17, 2017 through November 30, 2017. Amendment No. 11 included certain additional covenants including that, on or before October 20, 2017, the Company would deliver to the Bank an executed letter of intent from a third-party financial institution providing for refinancing and payment of the Company’s debt obligations to the Bank. Also, on October 17, 2017, the Registrant entered into Amendment No. 6 to the Note and Warrant Agreement among Registrant and BMO Private Equity (U.S.) Inc. (BMO Private Equity). In the Amendment, (i) the Company acknowledged its indebtedness to BMO Private Equity for a subordinated note in the principal amount of $5,000,000 and, for the balance under a note issued in connection with the conversion by BMO Private Equity of warrants, in the amount of $797,881, (ii) BMO Private Equity agreed to defer payment of interest due on October 2, 2017 in the amount of $150,139 to December 1, 2017. Amendment No. 6 includes covenants similar to that of Amendment No. 11 with the Bank.

 

On October 19, 2017, the Company delivered to the Bank and to BMO Equity an executed non-binding Preliminary Memorandum of Terms and Conditions (“Preliminary Term Sheet”) from a financing institution providing for an aggregate of up to $24,000,000 in senior secured financing to (i) refinance existing senior bank and mezzanine debt, (ii) fund certain capital expenditures and (iii) provide for ongoing working capital needs of Registrant. The Preliminary Term Sheet is non-binding and is subject to diligence and to the execution of a definitive agreement.

 

Management’s Plans.

 

Management is engaged in efforts to obtain re-financing of its obligations to BMO Harris and BMO Private Equity, is in accordance with the Preliminary Term Sheet and is engaged in a diligence and loan documentation process. While no assurance can be given that the re-financing will be completed, management has a reasonable expectation that both the re-financing will be completed and that the Company will continue as a going concern.

 

Management is also engaged in efforts to implement cost and operational improvements and to fulfill strong order flow in order to achieve profitable operations for the fourth quarter.

 

Seasonality

 

In the foil balloon product line, sales have historically been seasonal with approximately 40% occurring in the period from December through March of the succeeding year and 24% being generated in the period July through October in recent years. Vacuum sealing product sales are also seasonal; approximately 60% of sales in this product line occur in the period from July through December.

 

Critical Accounting Policies

 

Please see pages 25-28 of our Annual Report on Form 10-K for the year ended December 31, 2016 for a description of policies that are critical to our business operations and the understanding of our results of operations. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. No material changes to such information have occurred during the three months ended September 30, 2017.

 

  23  

 

 

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

As required by Rule 13a-15(b) under the Exchange Act, we conducted an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2017, the end of the period covered by this report. Based upon that evaluation, the Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2017, to ensure that the information required to be disclosed by us in the reports that we file or submit under Security Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including officers, as appropriate, to allow for timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the three months ended September 30, 2017 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

The Company is party to certain claims or actions arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the resolution of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

 

Item 1A. Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities

 

Not applicable.

 

Item 4. Submission of Matters to a Vote of Security Holders

 

Not applicable.

 

  24  

 

 

Item 5. Other Information

 

The Certifications of the Chief Executive Officer and the Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached as Exhibits to this Report on Form 10-Q.

 

Item 6. Exhibits

 

The following are being filed as exhibits to this report:

 

Exhibit
Number
 

 

Description

     
3.1   Restated Articles of Incorporation (Incorporated by reference to Exhibit A to Registrant’s Schedule 14A Definitive Proxy Statement filed April 29, 2015).
3.2   Amended and Restated By-Laws of CTI Industries Corporation (Incorporated by reference to Exhibit 3.2, contained in Registrant’s Form 8-K filed on March 17, 2017).
10.1   Senior Secured Subordinated Warrant Conversion Note between BMO Private Equity (U.S.) Inc. and the Company dated August 17, 2017.
10.2   Amendment No. 11 to Credit Agreement between BMO Harris Bank, N.A., BMO Private Equity (U.S.) Inc. and the Company dated October 17, 2017.
10.3   Amendment No. 6 to Note and Warrant Purchase Agreement between BMO Private Equity (U.S.) Inc. and the Company dated October 17, 2017.
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101  

Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements. 

 

  25  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Dated: November 14, 2017   CTI INDUSTRIES CORPORATION
     
    By: /s/ John H. Schwan
      John H. Schwan
      Chief Executive Officer
       
    By: /s/ Stephen M. Merrick
      Stephen M. Merrick
      President
       
    By: /s/ Timothy S. Patterson
      Timothy S. Patterson
      Chief Financial Officer
      Senior Vice President Finance

 

  26  

 

 

Exhibit Index

 

Exhibit
Number
   Description
3.1   Restated Articles of Incorporation (Incorporated by reference to Exhibit A to Registrant’s Schedule 14A Definitive Proxy Statement filed April 29, 2015.)
     
3.2   Amended and Restated By-Laws of CTI Industries Corporation (Incorporated by reference to Exhibit 3.2, contained in Registrant’s Form 8-K filed on March 17, 2017)
     
10.1   Senior Secured Subordinated Warrant Conversion Note between BMO Private Equity (U.S.) Inc. and the Company dated August 17, 2017.
     
10.2   Amendment No. 11 to Credit Agreement between BMO Harris Bank, N.A., BMO Private Equity (U.S.) Inc. and the Company dated October 17, 2017.
     
10.3   Amendment No. 6 to Note and Warrant Purchase Agreement between BMO Private Equity (U.S.) Inc. and the Company dated October 17, 2017.
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
     
32   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
     
101   Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements.

 

  27  

 

 

EXHIBIT 10.1

 

THIS WARRANT CONVERSION NOTE WAS ORIGINALLY ISSUED ON AUGUST 10, 2017, AND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE ILLINOIS SECURITIES LAW OF 1953, AS AMENDED, AND IT MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR AN OPINION FROM COUNSEL SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS NOT REQUIRED. The transfer of such security is subject to the conditions specified herein.

 

This Warrant Conversion Note is subject to the terms of a Subordination and Intercreditor Agreement dated as of July 17, 2012 (as amended, restated or supplemented from time to time, the “ Subordination Agreement ”) between BMO Private Equity (U.S.), Inc., a Delaware corporation, and BMO Harris Bank N.A. (formerly known as Harris N.A.).

 

SENIOR SECURED SUBORDINATED WARRANT CONVERSION NOTE

 

Dated:  August 17, 2017 $797,881.31
Effective Date:  August 10, 2017  

 

FOR VALUE RECEIVED, CTI Industries Corporation, an Illinois corporation (referred to herein as the “ Borrower ”), hereby promises to pay to the order of BMO Private Equity (U.S.), Inc., a Delaware corporation, or its assignee (the “ Holder ”), the principal amount of Seven Hundred Ninety-Seven Thousand Eight Hundred Eighty-One and 31/100 Dollars ($797,881.31) (the “ Original Principal Amount ”), together with interest thereon calculated from the effective date hereof (the “ Date of Issuance ”), in accordance with the provisions of this instrument (this “ Warrant Conversion Note ”). For purposes of this Warrant Conversion Note, the term “ Principal Balance ” shall mean an amount equal to (a) the sum of (i) the Original Principal Amount plus (ii) the aggregate amount of Interest (as defined below) capitalized and added to principal under this Warrant Conversion Note from time to time minus (b) all payments of principal made by the Borrower from time to time pursuant to the terms of this Warrant Conversion Note.

 

Reference is hereby made to that certain Note and Warrant Purchase Agreement dated as of July 17, 2012 (as amended, restated or otherwise modified from time to time, the “ Purchase Agreement ”), by and between the Borrower and the Holder. This Warrant Conversion Note was issued pursuant to the terms of the Warrant. This Warrant Conversion Note is the “Warrant Conversion Note” referred to in the Purchase Agreement. The Purchase Agreement contains terms governing the rights of the Holder of this Warrant Conversion Note and all provisions of the Purchase Agreement are hereby incorporated herein in full by reference. Except as otherwise indicated herein, capitalized terms used in this Warrant Conversion Note have the same meanings set forth in the Purchase Agreement.

 

 

 

 

1. Payment of Interest . Except as otherwise expressly provided herein, the Principal Balance of this Warrant Conversion Note shall bear interest (computed on the basis of actual days elapsed in a 360-day year) at the rate of eleven and 50/100 percent (11.50%) per annum (“ Interest ”). Interest accruing on the Principal Balance of this Warrant Conversion Note shall be compounded daily and capitalized as principal on each day during the term hereof and shall be payable in accordance with the payment schedule on Exhibit A attached hereto and made a part hereof (assuming for purposes of Exhibit A that no portion of the Principal Balance of this Warrant Conversion Note is prepaid and that this Warrant Conversion Note is not accelerated prior to the Maturity Date). The Interest accruing on the Principal Balance of this Warrant Conversion Note shall be payable to the Holder in cash upon the payment in full of the entire outstanding Principal Balance of this Warrant Conversion Note (whether on the Maturity Date or as a result of the acceleration of the maturity thereof), or if a prepayment of this Warrant Conversion Note is made, on the Principal Balance prepaid, and, if payment in full is not paid when due, thereafter on demand. Unless prohibited under applicable law, any accrued interest which is not paid on the date on which it is due and payable shall bear interest at the same rate at which interest is then accruing on the Principal Balance of this Note and, if applicable, shall be compounded daily and capitalized as principal on each day until such interest is paid. Any accrued interest which for any reason has not theretofore been paid shall be paid in full on the date on which the final principal payment on this Note is made. Interest shall accrue on any payment due under this Note until such time as payment therefor is actually delivered to the Holder. Notwithstanding anything to the contrary contained herein or in the Purchase Agreement, while any Event of Default exists or after acceleration, the Borrower shall pay interest (after as well as before entry of judgment thereon to the extent permitted by law) on the Principal Balance of the Warrant Conversion Note at the Default Rate and while in effect such interest accruing on the Principal Balance of this Warrant Conversion Note shall be compounded daily and capitalized as principal on each day.

 

2. Payment of Principal on Warrant Conversion Note .

 

(a) Scheduled Payment . The Principal Balance of this Warrant Conversion Note, plus accrued and unpaid interest, shall be payable in full on January 18, 2018 (the “ Maturity Date ”).

 

(b) Optional Prepayments . Subject to the terms of Section 2(c) below, the Borrower, at its option, may prepay all or any portion of this Warrant Conversion Note on any scheduled quarterly payment date set forth in the Note (as defined in the Purchase Agreement) at a prepayment price of one hundred percent (100%) of the Principal Balance to be prepaid, plus accrued and unpaid interest to the prepayment date.

 

(c) Prepayment Minimum . The Borrower, at its option, may at any time and from time to time prepay all or any portion of the Principal Balance of this Warrant Conversion Note, in minimum increments of $250,000, plus accrued and unpaid interest to the prepayment date. Except as provided herein, this Warrant Conversion Note may not be voluntarily prepaid by the Borrower.

 

 

 

 

(d) Notice of Prepayments . The Borrower shall give notice (which shall be irrevocable) to the Holder of this Warrant Conversion Note of each prepayment not later than 1:00 p.m. (Chicago time) on the Business Day that is not less than two (2) Business Days preceding the date of prepayment, specifying the aggregate Principal Balance to be prepaid and the prepayment date. Once any such notice has been given, the Principal Balance specified in such notice, together with all accrued and unpaid interest on the amount of each such prepayment to the date of payment shall become due and payable on such date of payment.

 

(e) Mandatory Prepayments .

 

(i) In the event of a Change of Control, the Borrower will, at least thirty (30) days and not more than sixty (60) days prior to such Change of Control, give written notice thereof to the holder of this Warrant Conversion Note, which shall contain a written irrevocable notice that the Borrower will prepay (a “ Prepayment Notice ”), by a date (the “ Prepayment Date ”) specified in such notice (which date shall be on or prior to the effective date of the Change of Control), all of the Obligations under the Warrant Conversion Note held by the holder in full (and not in part) in cash. Such notice may state that the Borrower’s prepayment is conditioned upon the consummation of such Change of Control. The Borrower shall pay to the holder the outstanding principal amount of the Warrant Conversion Note, together with all accrued and unpaid interest thereon.

 

(ii) Any notice by the Borrower to prepay the Warrant Conversion Note, and any subsequent prepayment thereof pursuant to this Section 2(e), shall be accompanied by an officer’s certificate (A) stating the principal amount of the Warrant Conversion Note to be prepaid, (B) stating the Prepayment Date, (C) stating the accrued interest on the Warrant Conversion Note to the Prepayment Date to be prepaid, (D) certifying that the conditions of this Section 2(e) have been fulfilled, and (E) specifying the nature of the Change of Control, the transactions or proposed transactions resulting in such Change of Control and the date or proposed date of the occurrence of such Change of Control.

 

3. Payment Schedule . Set forth as Exhibit A attached hereto is a schedule which reflects the amount of Interest which accrues and shall be capitalized and added to the Principal Balance pursuant to Section 1 above and the Principal Balance of this Warrant Conversion Note at the beginning and at the end of each day during the term of this Warrant Conversion Note (assuming for purposes of Exhibit A that no portion of the Principal Balance of this Warrant Conversion Note is prepaid and that this Warrant Conversion Note is not accelerated prior to the Maturity Date). Upon any voluntary or mandatory prepayment of the Principal Balance, the Interest reflected on Exhibit A attached hereto shall be recomputed based upon the remaining Principal Balance. The Holder shall amend Exhibit A hereto to reflect such recomputation and deliver the same to the Borrower, and such amended Exhibit A shall constitute rebuttable presumptive evidence of the Principal Balance owing and unpaid on this Warrant Conversion Note and the interest accruing and payable thereafter under this Warrant Conversion Note. The failure to amend Exhibit A hereto or to deliver the same to the Borrower shall not, however, affect the obligations of the Borrower to pay the Principal Balance and all accrued and unpaid interest on this Warrant Conversion Note.

 

 

 

 

4. Transfer and Exchange; Replacement; Cancellation .

 

(a) Transfer and Exchange .

 

(i) Subject to the transfer conditions referred to in this Section 4 and in the legends endorsed hereon, this Warrant Conversion Note and all rights hereunder are transferable by the Holder, in whole or in part, without charge to the Holder, upon surrender of this Warrant Conversion Note with a properly executed assignment in form and substance reasonably acceptable to the Borrower at the principal office of the Borrower.

 

(ii) Upon surrender of this Warrant Conversion Note for transfer or for exchange, the Borrower, at its expense, will (subject to the conditions set forth herein) execute and deliver in exchange therefor a new Warrant Conversion Note or Warrant Conversion Notes, as the case may be, as requested by the Holder or transferee, which aggregates the unpaid Principal Balance of such Warrant Conversion Note, issued as the Holder or such transferee may request, dated so that there will be no gain or loss of interest on such surrendered Warrant Conversion Note and otherwise of like tenor. The issuance of new Warrant Conversion Notes shall be made without charge to the Holder(s) of the surrendered Warrant Conversion Note for any issuance tax in respect thereof or other cost incurred by the Borrower in connection with such issuance.

 

(b) Replacement . Upon receipt of evidence reasonably satisfactory to the Borrower (an affidavit of the Holder of this Warrant Conversion Note shall be satisfactory) of the ownership and the loss, theft, destruction or mutilation of this Warrant Conversion Note and, in the case of any such loss, theft or destruction, upon receipt of indemnity reasonably satisfactory to the Borrower (provided that if the Holder is a financial institution or other institutional investor, its own agreement shall be satisfactory), or, in the case of any such mutilation, upon the surrender of this Warrant Conversion Note, the Borrower shall (at its expense) execute and deliver, in lieu thereof, a new Warrant Conversion Note of the same class and representing the same rights represented by such lost, stolen, destroyed or mutilated Warrant Conversion Note dated so that there will be no loss of interest on this Warrant Conversion Note.

 

 

 

 

5. Payments . All payments to be made to the Holder of this Warrant Conversion Note shall be made by wire transfer to the Holder in lawful money of the United States of America in same-day available funds. Any payment received by the Holder of this Warrant Conversion Note after 1:00 p.m. (Chicago time) on any day will be deemed to have been received on the next following Business Day.

 

6. Place of Payment . Payments of principal, interest and other amounts shall be made by wire transfer of immediately available funds to the following account of the Holder hereof:

 

ABA No.: 071 000 288

Account No.: 181-570-3

Account Name: BMO Private Equity (U.S.), Inc.

Bank: BMO Harris Bank N.A., Chicago, Illinois

Attention: Jason Swanson

 

or to such other account or to the attention of such other Person as specified by the Holder in a prior written notice to either Borrower.

 

7. Business Days . If any payment is due, or any time period for giving notice or taking action expires, on a day which is not a Business Day, the payment shall be due and payable on, and the time period shall automatically be extended to, the next Business Day immediately following, and interest shall continue to accrue at the required rate hereunder until any such payment is made.

 

8. Governing Law . This Warrant Conversion Note shall be governed and construed in accordance with the domestic laws of the State of Illinois, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Illinois or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Illinois.

 

9. Liabilities . In furtherance and not in limitation of the rights and remedies of the Holder of this Warrant Conversion Note hereunder or at law, the Holder of this Warrant Conversion Note may proceed under this Warrant Conversion Note against the Borrower in its absolute and sole discretion for any of the liabilities of the Borrower under this Warrant Conversion Note or any other liability or obligation of the Borrower arising hereunder.

 

10. Events of Default . Upon the occurrence of any “Event of Default,” as described and specified in the Purchase Agreement, the Holder shall have all of the rights and remedies in accordance with, and as provided by, the terms hereof and the Purchase Agreement. In addition, the Holder shall be entitled to recover from the Borrower any and all costs and expenses, including reasonable attorneys’ fees and court costs, incurred in enforcing its rights hereunder.

 

 

 

 

11. Usury Laws . It is the intention of the Borrower and the Holder of this Warrant Conversion Note to conform strictly to all applicable usury laws now or hereafter in force, and any interest payable under this Warrant Conversion Note shall be subject to reduction to an amount not in excess of the maximum legal amount allowed under the applicable usury laws as now or hereafter construed by the courts having jurisdiction over such matters. If the maturity of this Warrant Conversion Note is accelerated by reason of an election by the Holder hereof resulting from an Event of Default, voluntary prepayment by the Borrower or otherwise, then the earned interest may never include more than the maximum amount permitted by law, computed from the date hereof until payment, and any interest in excess of the maximum amount permitted by law shall be canceled automatically and, if theretofore paid, shall at the option of the Holder hereof either be rebated to the Borrower or credited on the Principal Balance of this Warrant Conversion Note, or if this Warrant Conversion Note has been paid, then the excess shall be rebated to the Borrower. The aggregate of all interest (whether designated as interest, service charges, points or otherwise) contracted for, chargeable, or receivable under this Warrant Conversion Note shall under no circumstances exceed the maximum legal rate upon the Principal Balance of this Warrant Conversion Note remaining unpaid from time to time. If such interest does exceed the maximum legal rate, it shall be deemed a mistake and such excess shall be canceled automatically and, if theretofore paid, at the option of the Holder hereof either be rebated to the Borrowers or credited on the Principal Balance of this Warrant Conversion Note, or if this Warrant Conversion Note has been repaid, then such excess shall be rebated to the Borrower.

 

12. Warrant Conversion Note in Registered Form . This Warrant Conversion Note is in registered form within the meaning of that term under Section 163(f) of the Code. The Borrower shall keep at its principal executive office a register in which the Borrower shall provide for the registration and transfer of the Warrant Conversion Note. The Holder of this Warrant Conversion Note, at such Holder’s option, may in person or by duly authorized attorney surrender this Warrant Conversion Note for exchange at the principal office of the Borrower, accompanied by a written opinion of legal counsel who shall be reasonably satisfactory to the Borrower, addressed to the Borrower and reasonably satisfactory in form and substance to the Borrower’s counsel, to the effect that the proposed exchange may be effected without registration under the Securities Act of 1933, as amended, or under any applicable state securities laws, to receive in exchange therefor a new Warrant Conversion Note or Warrant Conversion Notes, as may be requested by such Holder, of the same series and in the same aggregate unpaid principal amount as the aggregate unpaid principal amount of the Warrant Conversion Note or Warrant Conversion Notes so surrendered. Each such new Warrant Conversion Note shall be dated as of the date to which interest has been paid on the unpaid principal amount of the Warrant Conversion Note or Warrant Conversion Notes so surrendered and shall be in such principal amount and registered in such name or names as such Holder may designate in writing.

 

 

 

 

13. Binding Agreement . This Warrant Conversion Note shall be binding upon the Borrower and its successors and assigns, and shall inure to the benefit of the Holder and the benefit of its successors and assigns, including any subsequent holder of the Warrant Conversion Note. The Borrower may not assign its rights hereunder without the written consent of the Holder. This Agreement constitutes the entire understanding of the parties with respect to the subject matter hereof and any prior agreements, whether written or oral, with respect thereto are superseded hereby.

 

14. Fee Amount . For the avoidance of doubt, the Borrower hereby acknowledges and agrees that, based on the Date of Issuance of this Warrant Conversion Note, the fee referenced in Section 3 of Amendment No. 5 shall be in an amount equal to $3,425.17.

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

 

Senior Secured Subordinated Warrant Conversion Note Signature Page

 

IN WITNESS WHEREOF, the Borrower has caused this Warrant Conversion Note to be executed and delivered by a duly authorized officer as of the date first written above.

 

  CTI INDUSTRIES CORPORATION
   
  By: /s/ Timothy S. Patterson
  Name: Timothy S. Patterson
  Title: CFO

 

 

 

 

EXHIBIT A

 

(See attached)

 

 

 

 

EXHIBIT 10.2

 

AMENDMENT NO. 11 TO CREDIT AGREEMENT

 

This AMENDMENT NO. 11 TO CREDIT AGREEMENT (this " Agreement "), effective as of October 17, 2017, is by and between CTI INDUSTRIES CORPORATION, an Illinois corporation (the “Borrower”) and BMO HARRIS BANK N.A., a national banking association, successor to Harris N.A. (the “Bank”).

 

RECITALS :

 

WHEREAS, Bank and Borrower have entered into certain financing arrangements pursuant to that certain Credit Agreement dated as of April 29, 2010 (as amended hereby, and as the same may have heretofore been or may hereafter be further amended, modified, supplemented, extended, renewed, restated, replaced or otherwise modified, the " Credit Agreement "), by and among Borrower and Bank;

 

WHEREAS, Borrower has requested that, subject to the terms and conditions of this Agreement, Bank agrees to amend the Credit Agreement in certain respects; and

 

WHEREAS, Bank is willing to agree to amend the Credit Agreement in certain respects, in each case, subject to the terms and conditions specified herein.

 

NOW, THEREFORE, in consideration of the foregoing, and the respective agreements, warranties and covenants contained herein, the parties hereto agree as follows:

 

1.             DEFINITIONS

 

1.1.          Interpretation. All capitalized terms used herein (including the recitals hereto) will have the respective meanings ascribed thereto in the Credit Agreement unless otherwise defined herein. The foregoing recitals, together with all exhibits attached hereto, are incorporated by this reference and made a part of this Agreement. Unless otherwise provided herein, all section and exhibit references herein are to the corresponding sections and exhibits of this Agreement.

 

2.             ACKNOWLEDGMENTS

 

2.1.          Acknowledgment of Obligations. Borrower hereby acknowledges, confirms and agrees that as of October 12, 2017, prior to the effectiveness of this Agreement, (a) Borrower is indebted to Bank in respect of the Mortgage Loan in the aggregate principal amount of $1,664,456.62, (b) Borrower is indebted to Bank in respect of the Revolving Loans in the aggregate principal amount of $8,211,467.33, and (c) Borrower is indebted to Bank in respect of the Letters of Credit in the aggregate principal amount of $0. Borrower hereby acknowledges, confirms and agrees that all such Loans, together with interest accrued and accruing thereon, and all fees, costs, expenses and other charges now or hereafter payable by Borrower to Bank, are unconditionally owing by Borrower to Bank, without offset, defense or counterclaim of any kind, nature or description whatsoever.

 

 

 

 

2.2.          Acknowledgment of Security Interests. Borrower hereby acknowledges, confirms and agrees that Bank has, and will continue to have, valid, enforceable and perfected first-priority continuing liens upon and security interests in the Collateral heretofore granted to and for the benefit of Bank, pursuant to the Credit Agreement and the Loan Documents or otherwise granted to or held by Bank.

 

2.3.          Binding Effect of Documents. Borrower hereby acknowledges, confirms and agrees that: (a) this Agreement constitutes a Loan Document, (b) each of the Credit Agreement and the other Loan Documents to which it is a party has been duly executed and delivered to Bank by Borrower, and each is and will remain in full force and effect as of the date hereof except as modified pursuant hereto, (c) the agreements and obligations of Borrower contained in such documents and in this Agreement constitute the legal, valid and binding Obligations of Borrower, enforceable against it in accordance with their respective terms, and Borrower has no valid defense to the enforcement of such Obligations, and (d) Bank is and will be entitled to the rights, remedies and benefits provided for under the Credit Agreement and the other Loan Documents and applicable law.

 

2.4.          Acknowledgement of Additional Defaults . The parties hereto acknowledge, confirm and agree that any misrepresentation by Borrower, or any failure of Borrower to comply with the covenants, conditions and agreements contained in this Amendment will constitute an immediate Event of Default under the Credit Agreement and the other Loan Documents.

 

3.             AMENDMENT TO CREDIT AGREEMENT

 

In reliance upon the representations and warranties of Borrower set forth in Section 5 below and subject to the conditions to effectiveness set forth in Section 6 below:

 

3.1.           Section 5.1 of the Credit Agreement is hereby amended by amending and restating the following defined terms as follows:

 

Mortgage Loan Final Maturity Date ” means November 30, 2017, or such earlier date on which the Mortgage Loan is declared to be or becomes due pursuant to Section 9.2 or 9.3 hereof.

 

Revolving Credit Termination Date ” means November 30, 2017, or such earlier date on which the Revolving Credit Commitment is terminated in whole pursuant to Section 3.4, 9.2, or 9.3 hereof.

 

Temporary Overadvance Amount ” means (a) on and after October 17, 2017, through and including November 30, 2017, an amount equal to $1,000,000; and (b) at any other time (including on and after December 1, 2017), an amount equal to $0.

 

  2  

 

 

3.2.           Section 10.8 of the Credit Agreement is hereby amended by amending and restating the following contact information:

 

To the Lender:

BMO Harris Bank N.A.

115 S. LaSalle St. – 4W

Chicago, IL 60603
Attention: Lauren Wittert
Telephone No.: (312) 461-5188
Facsimile No.: (312) 461-7958

   
With copy to:

Goldberg Kohn Ltd.

55 East Monroe Street, Suite 3300

Chicago, Illinois 60603

Attention: Dimitri G. Karcazes

Telephone: (312) 201-3976

Facsimile: (312) 863-7476

 

4.             OTHER AGREEMENTS

 

4.1.           Agreement Regarding Borrowing Requests . Notwithstanding anything in the Credit Agreement to the contrary, Borrower hereby agrees not to request a Revolving Loan, and further agrees that Bank shall have no obligation to make a Revolving Loan, in excess of the amount necessary, as certified by the Chief Financial Officer of the Borrower in connection with any request for a Revolving Loan, for the uses of the proceeds thereof on account of disbursements to be made by Borrower in the ordinary course of business during the next one-week period.

 

4.2.           Updated Cash Flow Forecasts . On the first Business Day of each week (unless otherwise approved in writing by the Bank), Borrower shall deliver to Bank an updated 13-week cash flow forecast, in reasonable detail and in form and substance reasonably satisfactory to the Bank, showing projected cash receipts and disbursements (including referencing line item sources and uses of cash) of the Borrower and its Subsidiaries over the immediately succeeding 13-week period.

 

4.3.           Updated Perfection Certificate; Schedules . On or before October 20, 2017, Borrower shall deliver to Bank an updated perfection certificate and updated schedules to the Credit Agreement and the Security Agreement, each in reasonable detail and in form and substance reasonably satisfactory to Bank.

 

4.4.           Letter of Intent . On or before October 20, 2017, Borrower shall deliver to Bank a fully executed letter of intent (in form and substance acceptable to Bank) from a third-party financial institution (the " Proposed Lender ") that provides for the refinance and payment in full of the Obligations and a closing thereof within a timeframe acceptable to Bank in its sole discretion (the " Letter of Intent "). Borrower's failure to deliver a Letter of Intent required by this Section 4.4 shall not constitute an Event of Default; provided , however, that as a result of such failure, Borrower shall be required to comply with the covenant set forth in Section 4.6 below.

 

  3  

 

 

4.5.           Agreement to Retain Consultant. If (i) Borrower fails to deliver the Letter of Intent in accordance with Section 4.4 above, or (ii) at any time following the delivery of the Letter of Intent in accordance with Section 4.4 above, (a) the Proposed Lender notifies Borrower that it has elected to terminate the Letter of Intent or that the Proposed Lender will not continue to proceed toward the closing contemplated by the Letter of Intent, or (b) the Borrower is no longer pursuing the transaction contemplated by the Letter of Intent, as may be determined by the Bank in its reasonable discretion, upon the request by Bank, then within ten (10) days of the request of Bank, and at the sole expense of Borrower, Borrower shall hire or otherwise retain a consultant (the " Consultant ") acceptable to Bank, pursuant to an engagement letter, including the scope thereof, that has terms and conditions acceptable to Bank, to advise Borrower with respect to its business and operations and to pursue refinancing options. Borrower shall fully cooperate with the Consultant and shall authorize the Consultant to provide to Bank information and reports with respect to Borrower as Bank shall request from time to time, including, but not limited to, information and reports related to Borrower's financial condition, businesses, assets and liabilities and refinancing efforts and prospects.

 

4.6.           Bank Representatives . Borrower acknowledges and agrees that Bank may retain consultants or other advisors to assist and advise Bank, and agrees to provide such representatives access to the Borrower's and Subsidiary Guarantor's books, records, senior management and executives as such representatives may reasonable request from time to time. All amounts incurred by Bank in connection with such retentions and engagement of any such representatives shall constitute Obligations and be reimbursed by the Borrower pursuant to the Credit Agreement.

 

4.7.           Amendment Fee . In consideration of the transactions contemplated hereby, the Borrower hereby agrees to pay to the Bank an amendment fee (the " Amendment Fee ") in an amount equal to $7,500. The Amendment Fee shall be fully earned as of the date hereof and shall be due and payable in full on the date hereof. No portion of the Amendment Fee which is paid shall be subject to return or disgorgement.

 

5.             REPRESENTATIONS AND WARRANTIES

 

Borrower hereby represents, warrants and covenants as follows:

 

5.1.          Representations in the Credit Agreement and the Other Loan Documents. Each of the representations and warranties made by or on behalf of Borrower to Bank in the Credit Agreement or any of the other Loan Documents was true and correct when made, and is true and correct on and as of the date of this Agreement with the same full force and effect as if each of such representations and warranties had been made by Borrower on the date hereof and in this Agreement. All of the information contained in the schedules attached to the Credit Agreement and the Security Agreement remains true and correct as of the date hereof.

 

  4  

 

 

5.2.          Binding Effect of Documents. This Agreement has been duly authorized, executed and delivered to Bank by Borrower, is enforceable in accordance with its terms and is in full force and effect, except as the enforcement thereof may be subject to (i) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors' rights generally and (ii) general principles of equity (regardless of whether such enforcement is sought in a proceeding in equity or at law).

 

5.3.          No Conflict. The execution, delivery and performance of this Agreement by Borrower will not violate any requirement of law or contractual obligation of Borrower and will not result in, or require, the creation or imposition of any Lien on any of their respective properties or revenues.

 

6.            CONDITIONS TO EFFECTIVENESS OF CERTAIN PROVISIONS OF THIS AGREEMENT

 

The effectiveness of the terms and provisions of this Agreement (other than the terms and provisions of Sections 7.6 and 7.7, which will be effective immediately upon the execution of this Agreement) is subject to the following conditions precedent:

 

(a)          Bank's receipt of an original of this Agreement, duly authorized, executed and delivered by Borrower and Bank;

 

(b)          Bank's receipt of the Consent and Reaffirmation of Guarantors attached hereto as Exhibit 1 ;

 

(c)          Bank's receipt of fully executed copies of each of the other documents referenced on the Closing Checklist attached hereto as Exhibit 2, each of which shall be in form and substance acceptable to Bank, and the transactions contemplated by such documents shall have been consummated in accordance with the terms thereof; and

 

(d)          Bank's receipt of all fees and other amounts payable on or prior to the closing date of this Amendment, including all attorneys', consultants' and other professionals' fees and expenses incurred by Bank.

 

7.             MISCELLANEOUS

 

7.1.          Continuing Effect of Credit Agreement. Except as modified pursuant hereto, no other changes or modifications to the Credit Agreement or any other Loan Document are intended or implied by this Agreement and in all other respects the Credit Agreement and the other Loan Documents hereby are ratified, restated and confirmed by all parties hereto as of the date hereof. To the extent of any conflict between the terms of this Agreement, the Credit Agreement, and the other Loan Documents, the terms of this Agreement will govern and control. The Credit Agreement and this Agreement will be read and construed as one agreement.

 

7.2.          Costs and Expenses. In addition to, and without in any way limiting, the obligations of Borrowers set forth in Section 10.4 of the Credit Agreement, Borrower absolutely and unconditionally agrees to pay to Bank, on demand by Bank at any time, whether or not all or any of the transactions contemplated by this Agreement are consummated: all reasonable fees, costs and expenses incurred by Bank and any of its directors, officers, employees or agents (including, without limitation, reasonable fees, costs and expenses incurred of any counsel to Bank), regardless of whether Bank or any such other Person is a prevailing party, in connection with (a) the preparation, negotiation, execution, delivery or enforcement of this Agreement, the Credit Agreement, the other Loan Documents and any agreements, documents or instruments contemplated hereby and thereby, and (b) any investigation, litigation or proceeding related to this Agreement, the Credit Agreement or any other Loan Document or any act, omission, event or circumstance in any matter related to any of the foregoing.

 

  5  

 

 

7.3.          Further Assurances. At Borrower's expense, the parties hereto will execute and deliver such additional documents and take such further action as may be necessary or desirable to effectuate the provisions of this Agreement.

 

7.4.          Successors and Assigns; No Third-Party Beneficiaries. This Agreement will be binding upon and inure to the benefit of each of the parties hereto and their respective successors and assigns. No Person other than the parties hereto and, in the case of Sections 7.6 and 7.7 hereof, the Releasees, shall have any rights hereunder or be entitled to rely on this Agreement and all third-party beneficiary rights (other than the rights of the Releasees under Sections 7.6 and 7.7 hereof) are hereby expressly disclaimed.

 

7.5.          Survival of Representations, Warranties and Covenants. All representations, warranties, covenants and releases of Borrower made in this Agreement or any other document furnished in connection with this Agreement will survive the execution and delivery of this Agreement, and no investigation by Bank, or any closing, will affect the representations and warranties or the right of Bank to rely upon them.

 

7.6.          Release.

 

(a)          In consideration of the agreements of Bank contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the Borrower and the Subsidiary Guarantor, on behalf of itself and its successors and assigns, and its present and former members, managers, shareholders, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, consultants, financial advisors, legal representatives and other representatives (Borrower, the Subsidiary Guarantor, and all such other Persons being hereinafter referred to collectively as the " Releasing Parties " and individually as a " Releasing Party "), hereby absolutely, unconditionally and irrevocably releases, remises and forever discharges Bank, and each of its respective successors and assigns, and its respective present and former shareholders, members, managers, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, legal representatives and other representatives (Bank and all such other Persons being hereinafter referred to collectively as the " Releasees " and individually as a " Releasee "), of and from any and all demands, actions, causes of action, suits, damages and any and all other claims, counterclaims, defenses, rights of set-off, demands and liabilities whatsoever (individually, a " Claim " and collectively, " Claims ") of every kind and nature, known or unknown, suspected or unsuspected, at law or in equity, which any Releasing Party or any of its successors, assigns or other legal representatives may now or hereafter own, hold, have or claim to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to the date of this Agreement, including, without limitation, for or on account of, or in relation to, or in any way in connection with this Agreement, the Credit Agreement, any of the other Loan Documents or any of the transactions hereunder or thereunder.

 

  6  

 

 

(b)          Borrower and the Subsidiary Guarantor understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense to any Claim and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.

 

(c)          Borrower and the Subsidiary Guarantor agrees that no fact, event, circumstance, evidence or transaction which could now be asserted or which may hereafter be discovered will affect in any manner the final, absolute and unconditional nature of the release set forth above.

 

(d)          As to each and every claim released hereunder, Borrower and the Subsidiary Guarantor hereby represents that it has received the advice of legal counsel with regard to the releases contained herein. As to each and every claim released hereunder, Borrower and the Subsidiary Guarantor also waives the benefit of each other similar provision of applicable federal or state law (including without limitation the laws of the state of Illinois), if any, pertaining to general releases after having been advised by its legal counsel with respect thereto.

 

(e)          Borrower and the Subsidiary Guarantor hereunder hereby specifically acknowledges and agrees that: (i) none of the provisions of this Section 7.6 shall be construed as or constitute an admission of any liability on the part of Releasees; (ii) the provisions of this Section 7.6 shall constitute an absolute bar to any Claim of any kind, whether any such Claim is based on contract, tort, warranty, mistake or any other theory, whether legal, statutory or equitable; and (iii) any attempt to assert a Claim barred by the provisions of this Section 7.6 shall subject Borrower and the Subsidiary Guarantor hereunder to the provisions of applicable law setting forth the remedies for the bringing of groundless, frivolous or baseless claims or causes of action

 

7.7.          Covenant Not to Sue. Each Releasing Party hereby absolutely, unconditionally and irrevocably covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Releasee on the basis of any Claim released, remised and discharged by any Releasing Party pursuant to Section 7.6 above. If any Releasing Party violates the foregoing covenant, Borrower, for itself and its successors and assigns, and its present and former members, managers, shareholders, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, legal representatives and other representatives, agrees to pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys' fees and costs incurred by any Releasee as a result of such violation.

 

7.8.          Severability. Any provision of this Agreement held by a court of competent jurisdiction to be invalid or unenforceable will not impair or invalidate the remainder of this Agreement.

 

  7  

 

 

7.9.          Reviewed by Attorneys. Borrower and the Subsidiary Guarantor represent and warrant to Bank that each (a) understands fully the terms of this Agreement and the consequences of the execution and delivery of this Agreement, (b) has been afforded an opportunity to discuss this Agreement with, and have this Agreement reviewed by, such attorneys and other persons as Borrower may wish, and (c) has entered into this Agreement and executed and delivered all documents in connection herewith of its own free will and accord and without threat, duress or other coercion of any kind by any Person. The parties hereto acknowledge and agree that neither this Agreement nor the other documents executed pursuant hereto will be construed more favorably in favor of one than the other based upon which party drafted the same, it being acknowledged that all parties hereto contributed substantially to the negotiation and preparation of this Agreement and the other documents executed pursuant hereto or in connection herewith.

 

7.10.         Disgorgement . If Bank is, for any reason, compelled by a court or other tribunal of competent jurisdiction to surrender or disgorge any payment, interest or other consideration described hereunder to any person because the same is determined to be void or voidable as a preference, fraudulent conveyance, impermissible set-off or for any other reason, such indebtedness or part thereof intended to be satisfied by virtue of such payment, interest or other consideration will be revived and continue as if such payment, interest or other consideration had not been received by Bank, and Borrower will be liable to, and will indemnify, defend and hold Bank harmless for, the amount of such payment or interest surrendered or disgorged. The provisions of this Section will survive repayment of the Obligations or any termination of the Credit Agreement or any other Loan Document.

 

7.11.         Relationship . Borrower agrees that the relationship between Bank and Borrower is that of creditor and debtor and not that of partners or joint venturers. This Agreement does not constitute a partnership agreement or any other association between Bank and Borrower. Borrower acknowledges that Bank has acted at all times only as a creditor to Borrower within the normal and usual scope of the activities normally undertaken by a creditor and in no event has Bank attempted to exercise any control over Borrower or its business or affairs. Borrower further acknowledges that Bank has not taken or failed to take any action under or in connection with its respective rights under the Credit Agreement or any of the other Loan Documents that in any way or to any extent has interfered with or adversely affected Borrower's ownership of Collateral.

 

7.12.         Governing Law: Consent to Jurisdiction and Venue. EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THE CREDIT AGREEMENT AND ANY OF THE OTHER LOAN DOCUMENTS, THIS AGREEMENT, THE CREDIT AGREEMENT AND THE OTHER LOAN DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER WILL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF ILLINOIS, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES. BORROWER HEREBY CONSENTS AND AGREES THAT THE STATE OR FEDERAL COURTS LOCATED IN COOK COUNTY, ILLINOIS WILL HAVE EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN BORROWER AND BANK PERTAINING TO THIS AGREEMENT OR THE CREDIT AGREEMENT OR THE OTHER LOAN DOCUMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE CREDIT AGREEMENT OR ANY OF THE LOAN DOCUMENTS; AND FURTHER PROVIDED , THAT NOTHING IN THIS AGREEMENT WILL BE DEEMED OR OPERATE TO PRECLUDE BANK FROM BRINGING SUIT OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION TO COLLECT THE OBLIGATIONS, TO REALIZE ON THE COLLATERAL OR ANY OTHER SECURITY FOR THE OBLIGATIONS, OR TO ENFORCE A JUDGMENT OR OTHER COURT ORDER IN FAVOR OF BANK. EACH PARTY HEREUNDER EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE TO SUCH JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND HEREBY WAIVES ANY OBJECTION WHICH IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS AND HEREBY CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. EACH PARTY HEREUNDER HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS ISSUED IN ANY SUCH ACTION OR SUIT AND AGREES THAT SERVICE OF SUCH PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL ADDRESSED TO SUCH PARTY AT THE ADDRESS SET FORTH IN THE CREDIT AGREEMENT AND THAT SERVICE SO MADE WILL BE DEEMED COMPLETED UPON THE EARLIER OF SUCH PARTY'S ACTUAL RECEIPT THEREOF OR THREE (3) DAYS AFTER THE SAME HAS BEEN POSTED.

 

  8  

 

 

7.13.        Waivers.

 

(a)           Mutual Waiver of Jury Trial. THE PARTIES HERETO WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER ARISING IN CONTRACT, TORT OR OTHERWISE BETWEEN BANK AND BORROWER ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION WITH THIS AGREEMENT OR THE CREDIT AGREEMENT OR THE OTHER LOAN DOCUMENTS OR THE TRANSACTIONS RELATED THERETO.

 

(b)           Waivers by Borrower. Borrower hereby waive any rights Borrower may have upon payment in full of the Obligations to require Bank to terminate its security interest in the Collateral, other collateral or in any other property of Borrower until termination of the Credit Agreement in accordance with its terms and the execution by Borrower of an agreement indemnifying Bank from any loss or damage Bank may incur as the result of dishonored checks or other items of payment received by Bank from Borrower or any account debtor and applied to the obligations and releasing and indemnifying, in the same manner as described in Sections 7.6 and 7.7  of this Agreement, the Releasees from all claims arising on or before the date of such termination. Borrower acknowledges that the foregoing waiver is a material inducement to Bank in entering this Agreement and that Bank is relying upon the foregoing waiver in its future dealings with Borrower.

 

7.14.        Counterparts. This Agreement may be executed and delivered via facsimile or email (in .pdf format) transmission with the same force and effect as if an original were executed and may be executed in any number of counterparts, but all of such counterparts shall together constitute but one and the same agreement.

 

7.15.        Time is of the Essence. Time is of the essence respecting each and every covenant, condition and provision of this Agreement to be performed by Borrower.

 

[ signatures on following page ]

 

  9  

 

 

IN WITNESS WHEREOF, this Agreement is executed and delivered as of the day and year first above written.

 

  BORROWERS
   
  CTI INDUSTRIES CORPORATION
   
  By /s/ Stephen M. Merrick
  Name   Stephen M. Merrick
  Title   President  
   
  GUARANTOR
   
  CTI SUPPLY, INC.
   
  By   /s/ Stephen M. Merrick
  Name   Stephen M. Merrick
  Title   President

 

Signature Page to Amendment No. 11 to Credit Agreement  

 

 

 

 

  BANK
  BMO HARRIS BANK, N.A.
   
  By    /s/ Pam Wicker
  Name    Pam Wicker
  Title Director

 

Signature Page to Amendment No. 11 to Credit Agreement

 

 

 

 

EXHIBIT 1
to
AMENDMENT NO. 11 TO CREDIT AGREEMENT

 

CONSENT AND REAFFIRMATION OF SUBSIDIARY GUARANTOR

 

The undersigned (" Guarantor ") hereby (i) acknowledges receipt of a copy of the foregoing Amendment No. 11 to Credit Agreement (the " Agreement "; capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Credit Agreement (as defined in the Agreement)); (ii) consents to Borrower's execution and delivery of the Agreement; (iii) agrees to be bound by the Agreement, including, without limitation, Sections 7.6 and 7.7 of the Agreement as if Guarantor were a party thereto; (iv) affirms that nothing contained in the Agreement, except as specifically stated therein, will modify in any respect whatsoever any Loan Document to which it is a party; and (v) reaffirms its obligations under (a) that certain Guaranty of Subsidiary Guarantor dated as of April 29, 2010, by and among Guarantor and Bank and (b) each of the other Loan Documents to which it is a party (as modified by the Agreement, collectively, the " Reaffirmed Loan Documents ") and confirms that such obligations are unconditional and not subject to any defense, setoff, counterclaim or other adverse claim. Although Guarantor has been informed of the matters set forth herein and has acknowledged and agreed to same, Guarantor understands that Bank has no obligation to inform Guarantor of such matters in the future or to seek Guarantor's acknowledgment or agreement to future amendments, waivers or consents, and nothing herein creates such a duty.

 

The undersigned further agrees that after giving effect to the Agreement, each Reaffirmed Loan Document remains in full force and effect.

 

  CTI SUPPLY, INC.
   
  By:   /s/ Stephen M. Merrick
  Title:   President

 

Exhibit 1 to Amendment No. 11 to Credit Agreement

 

 

 

 

EXHIBIT 2
to
ELEVENTH AMENDMENT TO CREDIT AGREEMENT

 

CLOSING CHECKLIST

 

CLOSING DATE: October [__], 2017

 

parties to the transaction

 

BANK :  

BMO HARRIS BANK, N.A.

115 S. LaSalle St. – 4W

Chicago, IL 60603
Attention: Lauren Wittert
Telephone No.: (312) 461-5188
Facsimile No.: (312) 461-7958

     
BANK'S COUNSEL :  

GOLDBERG KOHN LTD.

55 East Monroe Street, Suite 3300

Chicago, Illinois 60603

Attn: Dimitri G. Karcazes and Danielle Wildern Juhle

Telephone No.: (312) 201-3976

Facsimile No.: (312) 863-7476

     
BORROWER :  

CTI INDUSTRIES CORPORATION
22160 N. Pepper Road

Lake Barrington, Illinois 60010
Attn: Stephen M. Merrick

Telephone: (847) 382-1000

Facsimile: (847) 382-1219

 

BORROWER'S COUNSEL :  

VANASCO, GENERALLY & MILLER

33 North LaSalle Street, Suite 2200

Chicago, Illinois 60602

Attn: Gerald Miller

Telephone No.: (312) 786-5100

Facsimile No.: (312) 786-5111

 

Exhibit 2 to Amendment No. 11 to Credit Agreement

 

 

 

 

A. Loan and Security Documents

 

(1) Amendment No. 11 to Credit Agreement

 

(2) Security Agreement (CTI Supply, Inc.)

 

(3) Amendment No. 2 to Pledge Agreement

 

(a) Stock Power Agreement

 

(b) Irrevocable Proxy Agreement

 

(c) CTI Supply, Inc. Stock Certificate

 

(4) Amendment No. 1 Patent and Trademark Agreement (Borrower)

 

(5) Copyright Security Agreement (Borrower)

 

(6) Amendment No. 1 to Mortgage and Security Agreement with Assignment of Rents

 

(a) Date Down Endorsement

 

(7) Amendment No. 6 to Note and Warrant Purchase Agreement

 

(8) Consent under Subordination and Intercreditor Agreement

 

(9) Secretary's Certificate (CTI Industries Corporation)

 

(a) Articles of Incorporation

 

(b) Bylaws

 

(c) Resolutions

 

(d) Incumbency

 

(10) Secretary's Certificate (CTI Supply, Inc.)

 

(a) Articles of Incorporation

 

(b) Bylaws

 

(c) Resolutions

 

(d) Incumbency

 

Exhibit 2 to Amendment No. 11 to Credit Agreement

 

 

 

 

EXHIBIT 10.3

 

AMENDMENT NO. 6 TO NOTE AND WARRANT PURCHASE AGREEMENT

 

This AMENDMENT NO. 6 TO NOTE AND WARRANT PURCHASE AGREEMENT (this “ Agreement ”), effective as of October 17, 2017, is by and between CTI INDUSTRIES CORPORATION, an Illinois corporation (“ Company ”), and BMO PRIVATE EQUITY (U.S.), INC., a Delaware corporation (“ Purchaser ”).

 

RECITALS :

 

WHEREAS, Purchaser and Company have entered into certain financing arrangements pursuant to that certain Note and Warrant Purchase Agreement dated as of July 17, 2012 (as amended hereby, and as the same may have heretofore been or may hereafter be further amended, modified, supplemented, extended, renewed, restated, replaced or otherwise modified, the “ Purchase Agreement ”), by and among Company and Purchaser, under which, among other things, (a) Company sold to Purchaser and Purchaser purchased from Company a note in the original principal amount of $5,000,000 and (b) in connection with the exercise of Purchaser’s put right under the Warrant, the Company issued a warrant conversion note to Purchaser in the original principal amount of $797,881.31;

 

WHEREAS, in connection with the Purchase Agreement, CTI Supply, Inc. , an Illinois corporation f/k/a CTI Helium, Inc., and a Wholly-Owned Subsidiary of the Company, in its capacity as a guarantor (the “ Subsidiary Guarantor ”), entered into a Guaranty dated as of July 17, 2012 (the “ Subsidiary Guaranty ”), under which, among other things, the Subsidiary Guarantor guarantees the prompt and complete payment and performance of the Obligations;

 

WHEREAS, Company has requested that, subject to the terms and conditions of this Agreement, Purchaser agree to amend the Purchase Agreement in certain respects; and

 

WHEREAS, Purchaser is willing to agree to amend the Purchase Agreement in certain respects, in each case, subject to the terms and conditions specified herein.

 

NOW, THEREFORE, in consideration of the foregoing, and the respective agreements, warranties and covenants contained herein, the parties hereto agree as follows:

 

1.             DEFINITIONS

 

1.1           Interpretation. All capitalized terms used herein (including the recitals hereto) will have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein. The foregoing recitals, together with all exhibits attached hereto, are incorporated by this reference and made a part of this Agreement. Unless otherwise provided herein, all section and exhibit references herein are to the corresponding sections and exhibits of this Agreement.

 

 

 

 

2.             ACKNOWLEDGMENTS

 

2.1           Acknowledgment of Obligations. Company hereby acknowledges, confirms and agrees that as of October 15, 2017, prior to the effectiveness of this Agreement, (a) Company is indebted to Purchaser in respect of the Note in the aggregate principal amount of $5,000,000, and (b) Company is indebted to Purchaser in respect of the Warrant Conversion Note in the aggregate principal amount of $815,139.46. Company hereby acknowledges, confirms and agrees that all such Obligations, together with interest accrued and accruing thereon, together with any paid-in-kind interest accrued and accruing thereon, and all fees, costs, expenses and other charges now or hereafter payable by Company to Purchaser, are unconditionally owing by Company to Purchaser, without offset, defense or counterclaim of any kind, nature or description whatsoever.

 

2.2           Acknowledgment of Security Interests. Company hereby acknowledges, confirms and agrees that Purchaser has, and will continue to have, valid, enforceable and perfected second-priority continuing liens upon and security interests in the Collateral heretofore granted to and for the benefit of Purchaser, pursuant to the Purchase Agreement and the Operative Documents or otherwise granted to or held by Purchaser.

 

2.3           Binding Effect of Documents. Company hereby acknowledges, confirms and agrees that: (a) this Agreement constitutes an Operative Document, (b) each of the Purchase Agreement and the other Operative Documents to which it is a party has been duly executed and delivered to Purchaser by Company, and each is and will remain in full force and effect as of the date hereof except as modified pursuant hereto, (c) the agreements and obligations of Company contained in such documents and in this Agreement constitute the legal, valid and binding Obligations of Company, enforceable against it in accordance with their respective terms, and Company has no valid defense to the enforcement of such Obligations, and (d) Purchaser is and will be entitled to the rights, remedies and benefits provided for under the Purchase Agreement and the other Operative Documents and applicable law.

 

2.4           Acknowledgement of Additional Defaults . The parties hereto acknowledge, confirm and agree that any misrepresentation by Company, or any failure of Company to comply with the covenants, conditions and agreements contained in this Amendment will constitute an immediate Event of Default under the Purchase Agreement and the other Operative Documents.

 

3.             AMENDMENT TO PURCHASE AGREEMENT

 

In reliance upon the representations and warranties of Company set forth in Section 5 below and subject to the conditions to effectiveness set forth in Section 6 below:

 

3.1            A new Section 3.4 is hereby added to the Purchase Agreement immediately following Section 3.3 thereof to read as follows:

 

Section 3.4           Certain Note Interest Payment . Notwithstanding anything contained in Section 1 of the Note to the contrary, effective as of October 2, 2017, the Current Interest payment in the amount of $150,138.89 due and payable on October 2, 2017 in respect of the Note has been deferred until, and is now due and payable on, December 1, 2017.”

 

  2  

 

 

3.2            Section 11.8 of the Purchase Agreement is hereby amended by amending and restating the following contact information:

 

To the Purchaser: BMO Private Equity (U.S.), Inc.
  111 West Monroe St.
  20th Floor East
  Chicago, IL 60603
  Attention:  Jason Swanson
  Telephone No.:  (312) 293-8196
  Facsimile No.:  [_____________________]
   
With copy to: Vedder Price P.C.
  222 North LaSalle Street, Suite 2400
  Chicago, Illinois  60601
  Attention:  Guy E. Snyder & Marie H. Godush
  Telephone:  (312) 609-7500
  Facsimile:  (312) 609-5005

 

4.             OTHER AGREEMENTS

 

4.1           Agreement Regarding Borrowing Requests . Notwithstanding anything in the Senior Credit Agreement to the contrary, Company hereby agrees not to request a Revolving Loan (as defined in the Senior Credit Agreement), and further agrees that Senior Lender shall have no obligation to make a Revolving Loan (as defined in the Senior Credit Agreement), in excess of the amount necessary, as certified by the Chief Financial Officer of the Company in connection with any request for a Revolving Loan (as defined in the Senior Credit Agreement), for the uses of the proceeds thereof on account of disbursements to be made by Company in the ordinary course of business during the next one-week period.

 

4.2           Updated Cash Flow Forecasts . On the first Business Day of each week (unless otherwise approved in writing by the Purchaser), Company shall deliver to Purchaser an updated 13-week cash flow forecast, in reasonable detail and in form and substance reasonably satisfactory to the Purchaser, showing projected cash receipts and disbursements (including referencing line item sources and uses of cash) of the Company and its Subsidiaries over the immediately succeeding 13-week period.

 

4.3           Updated Perfection Certificate; Schedules . On or before October 20, 2017, Company shall deliver to Purchaser an updated perfection certificate and updated schedules to the Purchase Agreement and the Security Agreement, each in reasonable detail and in form and substance reasonably satisfactory to Purchaser.

 

  3  

 

 

4.4           Letter of Intent . On or before October 20, 2017, Company shall deliver to Purchaser a fully executed letter of intent (in form and substance acceptable to Purchaser) from a third-party financial institution (the “ Proposed Lender ”) that provides for the refinance and payment in full of each of the Senior Debt and the Obligations, collectively, and a closing thereof within a timeframe acceptable to Purchaser in its sole discretion (the “ Letter of Intent ”). Company’s failure to deliver a Letter of Intent required by this Section 4.4 shall not constitute an Event of Default; provided , however, that as a result of such failure, Company shall be required to comply with the covenant set forth in Section 4.6 below.

 

4.5           [Reserved] .

 

4.6           Agreement to Retain Consultant . If (i) Company fails to deliver the Letter of Intent in accordance with Section 4.4 above, or (ii) at any time following the delivery of the Letter of Intent in accordance with Section 4.4 above, (a) the Proposed Lender notifies Company that it has elected to terminate the Letter of Intent or that the Proposed Lender will not continue to proceed toward the closing contemplated by the Letter of Intent, or (b) the Company is no longer pursuing the transaction contemplated by the Letter of Intent, as may be determined by the Purchaser and the Senior Lender in their reasonable discretion, upon the request by Senior Lender, then within ten (10) days of the request of Senior Lender, and at the sole expense of Company, Company shall hire or otherwise retain a consultant (the “ Consultant ”) acceptable to Senior Lender and Purchaser, pursuant to an engagement letter, including the scope thereof, that has terms and conditions acceptable to Purchaser, to advise Company with respect to its business and operations and to pursue refinancing options. Company shall fully cooperate with the Consultant and shall authorize the Consultant to provide to Purchaser information and reports with respect to Company as Purchaser shall request from time to time, including, but not limited to, information and reports related to Company’s financial condition, businesses, assets and liabilities and refinancing efforts and prospects.

 

4.7           Purchaser Representatives . Company acknowledges and agrees that Purchaser may retain consultants or other advisors to assist and advise Purchaser, and agrees to provide such representatives access to the Company’s and Subsidiary Guarantor’s books, records, senior management and executives as such representatives may reasonably request from time to time. All amounts incurred by Purchaser in connection with such retentions and engagement of any such representatives shall constitute Obligations and be reimbursed by the Company pursuant to the Purchase Agreement.

 

4.8           Amendment Fee . In consideration of the transactions contemplated hereby, the Company hereby agrees to pay to Purchaser an amendment fee (the “ Amendment Fee ”) in an amount equal to $14,500. The Amendment Fee shall be fully earned as of the date hereof and shall be due and payable in full in cash on or before December 1, 2017. No portion of the Amendment Fee which is paid shall be subject to return or disgorgement.

 

5.             REPRESENTATIONS AND WARRANTIES

 

Company hereby represents, warrants and covenants as follows:

 

5.1           Representations in the Purchase Agreement and the Other Operative Documents. Each of the representations and warranties made by or on behalf of Company to Purchaser in the Purchase Agreement or any of the other Operative Documents, and to Senior Lender in the Senior Credit Agreement or any of the other Senior Credit Documents, was true and correct when made, and is true and correct on and as of the date of this Agreement with the same full force and effect as if each of such representations and warranties had been made by Company on the date hereof and in this Agreement. All of the information contained in the schedules attached to the Purchase Agreement and the Security Agreement remains true and correct as of the date hereof.

 

  4  

 

 

5.2           Binding Effect of Documents. This Agreement has been duly authorized, executed and delivered to Purchaser by Company, is enforceable in accordance with its terms and is in full force and effect, except as the enforcement thereof may be subject to (i) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors’ rights generally and (ii) general principles of equity (regardless of whether such enforcement is sought in a proceeding in equity or at law).

 

5.3           No Conflict. The execution, delivery and performance of this Agreement by Company will not violate any requirement of law or contractual obligation of Company and will not result in, or require, the creation or imposition of any Lien on any of their respective properties or revenues.

 

6.             CONDITIONS TO EFFECTIVENESS OF CERTAIN PROVISIONS OF THIS AGREEMENT

 

The effectiveness of the terms and provisions of this Agreement (other than the terms and provisions of Sections 7.6 and 7.7, which will be effective immediately upon the execution of this Agreement) is subject to the following conditions precedent:

 

(a)          Purchaser’s receipt of an original of this Agreement, duly authorized, executed and delivered by Company and Purchaser;

 

(b)          Purchaser’s receipt of the Consent and Reaffirmation of Subsidiary Guarantor attached hereto as Exhibit 1 ;

 

(c)          Purchaser’s receipt of fully executed copies of each of the other documents referenced on the Closing Checklist attached hereto as Exhibit 2, each of which shall be in form and substance acceptable to Purchaser, and the transactions contemplated by such documents shall have been consummated in accordance with the terms thereof; and

 

(d)          Purchaser’s receipt of all fees and other amounts payable on or prior to the closing date of this Amendment, including all attorneys’, consultants’ and other professionals’ fees and expenses incurred by Purchaser.

 

7.             MISCELLANEOUS

 

7.1           Continuing Effect of Purchase Agreement . Except as modified pursuant hereto, no other changes or modifications to the Purchase Agreement or any other Operative Document are intended or implied by this Agreement and in all other respects the Purchase Agreement and the other Operative Documents hereby are ratified, restated and confirmed by all parties hereto as of the date hereof. To the extent of any conflict between the terms of this Agreement, the Purchase Agreement, and the other Operative Documents, the terms of this Agreement will govern and control. The Purchase Agreement and this Agreement will be read and construed as one agreement.

 

  5  

 

 

7.2           Costs and Expenses . In addition to, and without in any way limiting, the obligations of Company set forth in Section 11.4 of the Purchase Agreement, Company absolutely and unconditionally agrees to pay to Purchaser, on demand by Purchaser at any time, whether or not all or any of the transactions contemplated by this Agreement are consummated: all reasonable fees, costs and expenses incurred by Purchaser and any of its directors, officers, employees or agents (including, without limitation, reasonable fees, costs and expenses incurred of any counsel to Purchaser), regardless of whether Purchaser or any such other Person is a prevailing party, in connection with (a) the preparation, negotiation, execution, delivery or enforcement of this Agreement, the Purchase Agreement, the other Operative Documents and any agreements, documents or instruments contemplated hereby and thereby, and (b) any investigation, litigation or proceeding related to this Agreement, the Purchase Agreement or any other Operative Document or any act, omission, event or circumstance in any matter related to any of the foregoing.

 

7.3           Further Assurances . At Company’s expense, the parties hereto will execute and deliver such additional documents and take such further action as may be necessary or desirable to effectuate the provisions of this Agreement.

 

7.4           Successors and Assigns; No Third-Party Beneficiaries . This Agreement will be binding upon and inure to the benefit of each of the parties hereto and their respective successors and assigns. No Person other than the parties hereto and, in the case of Sections 7.6 and 7.7 hereof, the Releasees, shall have any rights hereunder or be entitled to rely on this Agreement and all third-party beneficiary rights (other than the rights of the Releasees under Sections 7.6 and 7.7 hereof) are hereby expressly disclaimed.

 

7.5           Survival of Representations, Warranties and Covenants. All representations, warranties, covenants and releases of Company made in this Agreement or any other document furnished in connection with this Agreement will survive the execution and delivery of this Agreement, and no investigation by Purchaser, or any closing, will affect the representations and warranties or the right of Purchaser to rely upon them.

 

7.6           Release .

 

(a)          In consideration of the agreements of Purchaser contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the Company and the Subsidiary Guarantor, on behalf of itself and its successors and assigns, and its present and former members, managers, shareholders, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, consultants, financial advisors, legal representatives and other representatives (Company, the Subsidiary Guarantor, and all such other Persons being hereinafter referred to collectively as the “ Releasing Parties ” and individually as a “ Releasing Party ”), hereby absolutely, unconditionally and irrevocably releases, remises and forever discharges Purchaser, and each of its respective successors and assigns, and its respective present and former shareholders, members, managers, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, legal representatives and other representatives (Purchaser and all such other Persons being hereinafter referred to collectively as the “ Releasees ” and individually as a “ Releasee ”), of and from any and all demands, actions, causes of action, suits, damages and any and all other claims, counterclaims, defenses, rights of set-off, demands and liabilities whatsoever (individually, a “ Claim ” and collectively, “ Claims ”) of every kind and nature, known or unknown, suspected or unsuspected, at law or in equity, which any Releasing Party or any of its successors, assigns or other legal representatives may now or hereafter own, hold, have or claim to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to the date of this Agreement, including, without limitation, for or on account of, or in relation to, or in any way in connection with this Agreement, the Purchase Agreement, any of the other Operative Documents or any of the transactions hereunder or thereunder.

 

  6  

 

 

(b)          Company and the Subsidiary Guarantor understands, acknowledges and agrees that the release set forth above may be pleaded as a full and complete defense to any Claim and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.

 

(c)          Company and the Subsidiary Guarantor agrees that no fact, event, circumstance, evidence or transaction which could now be asserted or which may hereafter be discovered will affect in any manner the final, absolute and unconditional nature of the release set forth above.

 

(d)          As to each and every claim released hereunder, Company and the Subsidiary Guarantor hereby represents that it has received the advice of legal counsel with regard to the releases contained herein. As to each and every claim released hereunder, Company and the Subsidiary Guarantor also waives the benefit of each other similar provision of applicable federal or state law (including without limitation the laws of the state of Illinois), if any, pertaining to general releases after having been advised by its legal counsel with respect thereto.

 

(e)          Company and the Subsidiary Guarantor hereunder hereby specifically acknowledges and agrees that: (i) none of the provisions of this Section 7.6 shall be construed as or constitute an admission of any liability on the part of Releasees; (ii) the provisions of this Section 7.6 shall constitute an absolute bar to any Claim of any kind, whether any such Claim is based on contract, tort, warranty, mistake or any other theory, whether legal, statutory or equitable; and (iii) any attempt to assert a Claim barred by the provisions of this Section 7.6 shall subject Company and the Subsidiary Guarantor hereunder to the provisions of applicable law setting forth the remedies for the bringing of groundless, frivolous or baseless claims or causes of action.

 

7.7           Covenant Not to Sue . Each Releasing Party hereby absolutely, unconditionally and irrevocably covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Releasee on the basis of any Claim released, remised and discharged by any Releasing Party pursuant to Section 7.6 above. If any Releasing Party violates the foregoing covenant, Company, for itself and its successors and assigns, and its present and former members, managers, shareholders, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents, legal representatives and other representatives, agrees to pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys’ fees and costs incurred by any Releasee as a result of such violation.

 

  7  

 

 

7.8           Severability . Any provision of this Agreement held by a court of competent jurisdiction to be invalid or unenforceable will not impair or invalidate the remainder of this Agreement.

 

7.9           Reviewed by Attorneys . Company and the Subsidiary Guarantor represent and warrant to Purchaser that each (a) understands fully the terms of this Agreement and the consequences of the execution and delivery of this Agreement, (b) has been afforded an opportunity to discuss this Agreement with, and have this Agreement reviewed by, such attorneys and other persons as Company may wish, and (c) has entered into this Agreement and executed and delivered all documents in connection herewith of its own free will and accord and without threat, duress or other coercion of any kind by any Person. The parties hereto acknowledge and agree that neither this Agreement nor the other documents executed pursuant hereto will be construed more favorably in favor of one than the other based upon which party drafted the same, it being acknowledged that all parties hereto contributed substantially to the negotiation and preparation of this Agreement and the other documents executed pursuant hereto or in connection herewith.

 

7.10         Disgorgement . If Purchaser is, for any reason, compelled by a court or other tribunal of competent jurisdiction to surrender or disgorge any payment, interest or other consideration described hereunder to any person because the same is determined to be void or voidable as a preference, fraudulent conveyance, impermissible set-off or for any other reason, such indebtedness or part thereof intended to be satisfied by virtue of such payment, interest or other consideration will be revived and continue as if such payment, interest or other consideration had not been received by Purchaser, and Company will be liable to, and will indemnify, defend and hold Purchaser harmless for, the amount of such payment or interest surrendered or disgorged. The provisions of this Section will survive repayment of the Obligations or any termination of the Purchase Agreement or any other Operative Document.

 

7.11         Relationship . Company agrees that the relationship between Purchaser and Company is that of creditor and debtor and not that of partners or joint venturers. This Agreement does not constitute a partnership agreement or any other association between Purchaser and Company. Company acknowledges that Purchaser has acted at all times only as a creditor to Company within the normal and usual scope of the activities normally undertaken by a creditor and in no event has Purchaser attempted to exercise any control over Company or its business or affairs. Company further acknowledges that Purchaser has not taken or failed to take any action under or in connection with its respective rights under the Purchase Agreement or any of the other Operative Documents that in any way or to any extent has interfered with or adversely affected Company’s ownership of Collateral.

 

  8  

 

 

7.12         Governing Law: Consent to Jurisdiction and Venue . EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THE PURCHASE AGREEMENT AND ANY OF THE OTHER OPERATIVE DOCUMENTS, THIS AGREEMENT, THE PURCHASE AGREEMENT AND THE OTHER OPERATIVE DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER WILL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF ILLINOIS, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES. COMPANY HEREBY CONSENTS AND AGREES THAT THE STATE OR FEDERAL COURTS LOCATED IN COOK COUNTY, ILLINOIS WILL HAVE EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN COMPANY AND PURCHASER PERTAINING TO THIS AGREEMENT OR THE PURCHASE AGREEMENT OR THE OTHER OPERATIVE DOCUMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE PURCHASE AGREEMENT OR ANY OF THE OPERATIVE DOCUMENTS; AND FURTHER PROVIDED , THAT NOTHING IN THIS AGREEMENT WILL BE DEEMED OR OPERATE TO PRECLUDE PURCHASER FROM BRINGING SUIT OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION TO COLLECT THE OBLIGATIONS, TO REALIZE ON THE COLLATERAL OR ANY OTHER SECURITY FOR THE OBLIGATIONS, OR TO ENFORCE A JUDGMENT OR OTHER COURT ORDER IN FAVOR OF PURCHASER. EACH PARTY HEREUNDER EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE TO SUCH JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND HEREBY WAIVES ANY OBJECTION WHICH IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS AND HEREBY CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. EACH PARTY HEREUNDER HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS ISSUED IN ANY SUCH ACTION OR SUIT AND AGREES THAT SERVICE OF SUCH PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL ADDRESSED TO SUCH PARTY AT THE ADDRESS SET FORTH IN THE PURCHASE AGREEMENT AND THAT SERVICE SO MADE WILL BE DEEMED COMPLETED UPON THE EARLIER OF SUCH PARTY’S ACTUAL RECEIPT THEREOF OR THREE (3) DAYS AFTER THE SAME HAS BEEN POSTED.

 

7.13        Waivers .

 

(a)           Mutual Waiver of Jury Trial . THE PARTIES HERETO WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER ARISING IN CONTRACT, TORT OR OTHERWISE BETWEEN PURCHASER AND COMPANY ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION WITH THIS AGREEMENT OR THE PURCHASE AGREEMENT OR THE OTHER OPERATIVE DOCUMENTS OR THE TRANSACTIONS RELATED THERETO.

 

(b)           Waivers by Company . Company hereby waives any rights Company may have upon payment in full of the Obligations to require Purchaser to terminate its security interest in the Collateral, other collateral or in any other property of Company until termination of the Purchase Agreement in accordance with its terms and the execution by Company of an agreement indemnifying Purchaser from any loss or damage Purchaser may incur as the result of dishonored checks or other items of payment received by Purchaser from Company or any account debtor and applied to the obligations and releasing and indemnifying, in the same manner as described in Sections 7.6 and 7.7 of this Agreement, the Releasees from all claims arising on or before the date of such termination. Company acknowledges that the foregoing waiver is a material inducement to Purchaser in entering this Agreement and that Purchaser is relying upon the foregoing waiver in its future dealings with Company.

 

  9  

 

 

7.14         Counterparts . This Agreement may be executed and delivered via facsimile or email (in .pdf format) transmission with the same force and effect as if an original were executed and may be executed in any number of counterparts, but all of such counterparts shall together constitute but one and the same agreement.

 

7.15         Time is of the Essence . Time is of the essence respecting each and every covenant, condition and provision of this Agreement to be performed by Company.

 

[ signatures on following page ]

 

  10  

 

 

IN WITNESS WHEREOF, this Agreement is executed and delivered as of the day and year first above written.

 

  COMPANY
   
  CTI INDUSTRIES CORPORATION
   
  By /s/ Stephen M. Merrick
  Name   Stephen M. Merrick
  Title    President
   
  SUBSIDIARY GUARANTOR
   
  CTI SUPPLY, INC.
   
  By /s/ Stephen M. Merrick
  Name   Stephen M. Merrick
  Title   President

 

Signature Page to Amendment No. 6 to Note and Warrant Purchase Agreement

 

 

 

 

  PURCHASER
   
  BMO PRIVATE EQUITY (U.S.), INC. ,
   
  By /s/ Jason Swanson
  Name   Jason Swanson
  Title   Managing Director

 

Signature Page to Amendment No. 6 to Note and Warrant Purchase Agreement

 

 

 

 

EXHIBIT 1
to
AMENDMENT NO. 6 TO NOTE AND WARRANT PURCHASE AGREEMENT

 

CONSENT AND REAFFIRMATION OF SUBSIDIARY GUARANTOR

 

The undersigned (“ Subsidiary Guarantor ”) hereby (i) acknowledges receipt of a copy of the foregoing Amendment No. 6 to Note and Warrant Purchase Agreement (the “ Agreement ”; capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Purchase Agreement (as defined in the Agreement)); (ii) consents to Company’s execution and delivery of the Agreement; (iii) agrees to be bound by the Agreement, including, without limitation, Sections 7.6 and 7.7 of the Agreement as if Subsidiary Guarantor were a party thereto; (iv) affirms that nothing contained in the Agreement, except as specifically stated therein, will modify in any respect whatsoever any Operative Document to which it is a party; and (v) reaffirms its obligations under (a) that certain Guaranty of Subsidiary Guarantor dated as of July 17, 2012, by and among Subsidiary Guarantor and Purchaser and (b) each of the other Operative Documents to which it is a party (as modified by the Agreement, collectively, the “ Reaffirmed Operative Documents ”) and confirms that such obligations are unconditional and not subject to any defense, setoff, counterclaim or other adverse claim. Although Subsidiary Guarantor has been informed of the matters set forth herein and has acknowledged and agreed to same, Subsidiary Guarantor understands that Purchaser has no obligation to inform Subsidiary Guarantor of such matters in the future or to seek Subsidiary Guarantor’s acknowledgment or agreement to future amendments, waivers or consents, and nothing herein creates such a duty.

 

The undersigned further agrees that after giving effect to the Agreement, each Reaffirmed Operative Document remains in full force and effect.

 

  CTI SUPPLY, INC.
   
  By:   /s/ Stephen M. Merrick
  Name   Stephen M. Merrick
  Title:   President

 

Exhibit 1 to Amendment No. 6 to Note and Warrant Purchase Agreement

 

 

 

 

EXHIBIT 2
to
AMENDMENT NO. 6 TO NOTE AND WARRANT PURCHASE AGREEMENT

 

CLOSING CHECKLIST

 

CLOSING DATE: October 17, 2017

 

parties to the transaction

 

PURCHASER : BMO PRIVATE EQUITY (U.S.), INC.
111 S. LaSalle St.
20th Floor East
Chicago, IL 60603
Attention:  Jason Swanson
Telephone No.:  (312) 293-8196
Facsimile No.:   [            ]
   
PURCHASER’S COUNSEL : VEDDER PRICE P.C.
222 N. LaSalle Street, Suite 2400
Chicago, Illinois  60601
Attn:  Guy Snyder and Marie H. Godush
Telephone No.:  (312) 609-7500
Facsimile No.:  (312) 609-5005
   
COMPANY : CTI INDUSTRIES CORPORATION
22160 N. Pepper Road
Lake Barrington, Illinois  60010
Attn:  Stephen M. Merrick
Telephone:  (847) 382-1000
Facsimile:  (847) 382-1219
   
COMPANY’S COUNSEL : VANASCO, GENERALLY & MILLER
33 North LaSalle Street, Suite 2200
Chicago, Illinois 60602
Attn:  Gerald Miller
Telephone No.:  (312) 786-5100
Facsimile No.:  (312) 786-5111

 

Exhibit 2 to Amendment No. 6 to Note and Warrant Purchase Agreement

 

 

 

 

A. Operative and Security Documents

 

(1) Amendment No. 6 to Note and Warrant Purchase Agreement

 

(2) Security Agreement (CTI Supply, Inc.)

 

(3) Amendment No. 1 to Pledge Agreement

 

(a) Copy of Stock Power Agreement (being held by Senior Lender)

 

(b) Irrevocable Proxy Agreement

 

(c) Copy of CTI Supply, Inc. Stock Certificate (being held by Senior Lender)

 

(4) Amendment No. 1 Patent and Trademark Agreement (Company)

 

(5) Copyright Security Agreement (Company)

 

(6) Amended and Restated Junior Mortgage and Security Agreement with Assignment of Rents

 

(a) Title Commitment

 

(7) Amendment No. 11 to Senior Credit Agreement

 

(8) Consent under Subordination and Intercreditor Agreement

 

(9) Secretary’s Certificate (CTI Industries Corporation)

 

(a) Articles of Incorporation

 

(b) Bylaws

 

(c) Resolutions

 

(d) Incumbency

 

(10) Secretary’s Certificate (CTI Supply, Inc.)

 

(a) Articles of Incorporation

 

(b) Bylaws

 

(c) Resolutions

 

(d) Incumbency

 

(11) UCC-1 Financing Statement (CTI Supply, Inc.)

 

(12) Lien Searches

 

Exhibit 2 to Amendment No. 6 to Note and Warrant Purchase Agreement

 

 

 

EXHIBIT 31.1

CERTIFICATIONS

 

I, John H. Schwan, certify that:

 

1.       I have reviewed this quarterly report on Form 10-Q of CTI Industries Corporation.

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14, 2017

  /s/ John H. Schwan
  John H. Schwan,
  Chief Executive Officer

 

 

 

EXHIBIT 31.2

CERTIFICATIONS

 

I, Timothy S. Patterson, certify that:

 

1.       I have reviewed this quarterly report on Form 10-Q of CTI Industries Corporation.

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.       The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14, 2017

 

  By: /s/ Timothy S. Patterson
    Timothy S. Patterson
    Chief Financial Officer
    Senior Vice President Finance

 

 

 

Exhibit 32

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of CTI Industries Corporation (the “Company”) for the quarterly period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), John H. Schwan, as Chief Executive Officer of the Company, and Timothy S. Patterson, as Senior Vice President Finance and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ John H. Schwan  
John H. Schwan  
Chief Executive Officer  

 

Date: November 14, 2017

 

/s/ Timothy S. Patterson  
Timothy S. Patterson  
Chief Financial Officer  
Senior Vice President Finance  

 

Date: November 14, 2017

 

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32 is expressly and specifically incorporated by reference in any such filing.

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.